<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Exp Clin Cancer Res</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Exp. Clin. Cancer Res</journal-id>
<journal-title-group>
<journal-title>Journal of Experimental &amp; Clinical Cancer Research : CR</journal-title>
</journal-title-group>
<issn pub-type="ppub">0392-9078</issn>
<issn pub-type="epub">1756-9966</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30217221</article-id>
<article-id pub-id-type="pmc">6138891</article-id>
<article-id pub-id-type="publisher-id">898</article-id>
<article-id pub-id-type="doi">10.1186/s13046-018-0898-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Regulation of PTEN expression by noncoding RNAs</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Wang</given-names>
</name>
<address>
<email>liyonghao2008@qq.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Ting</given-names>
</name>
<address>
<email>928728022@qq.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guo</surname>
<given-names>Lianying</given-names>
</name>
<address>
<email>guolianying@163.com</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Huang</surname>
<given-names>Lin</given-names>
</name>
<address>
<phone>86-411-86118661</phone>
<email>lhuang@dmu.edu.cn</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9558 1426</institution-id><institution-id institution-id-type="GRID">grid.411971.b</institution-id><institution>Department of Pathophysiology, College of Basic Medical Sciences, </institution><institution>Dalian Medical University, </institution></institution-wrap>Dalian, Liaoning 116044 People’s Republic of China </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>10</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>10</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>37</volume>
<elocation-id>223</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>1</day>
<month>9</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Phosphatase and tensin homologue (PTEN) triggers a battery of intracellular signaling pathways, especially PI3K/Akt, playing important roles in the pathogenesis of multiple diseases, such as cancer, neurodevelopmental disorders, cardiovascular dysfunction and so on. Therefore PTEN might be a biomarker for various diseases, and targeting the abnormal expression level of PTEN is anticipated to offer novel therapeutic avenues. Recently, noncoding RNAs (ncRNAs) have been reported to regulate protein expression, and it is definite that PTEN expression is controlled by ncRNAs epigenetically or posttranscriptionally as well. Herein, we provide a review on current understandings of the regulation of PTEN by ncRNAs, which could contribute to the development of novel approaches to the diseases with abnormal expression of PTEN.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>PTEN</kwd>
<kwd>Noncoding RNA</kwd>
<kwd>miRNA</kwd>
<kwd>lncRNA</kwd>
<kwd>Methylation</kwd>
<kwd>ceRNA</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
<institution>National Natural Science Foundation of China</institution>
</institution-wrap>
</funding-source>
<award-id>81772971</award-id>
<principal-award-recipient>
<name>
<surname>Huang</surname>
<given-names>Lin</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Climbing Scholars Supporting Program of Liaoning</institution>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par49"><italic>Phosphatase and tensin homologue (PTEN)</italic>, also named as <italic>MMAC1</italic> (mutated in multiple advanced cancers), is located on chromosome 10q23.31 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. <italic>PTEN</italic> encodes a 403-amino acid peptide, which is composed of a phosphatidylinositol-4,5-bisphosphate-binding domain (PBD) (residues 1–13), a catalytic phosphatase domain (PD) (residues 14–185), a C2 membrane binding domain (C2D)(residues 186–350), and a C-terminal tail (residues 351–403) [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. The PD includes a conserved catalytic motif HCKAGKGR, contributing to the dual lipid and protein phosphatase activity of PTEN [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. The C2 domain includes two tyrosine phosphorylation sites (Y240 and Y315). The PDZ-binding domain (post-synaptic density protein (PSD95), Drosophila discs large (Dlg) and the tight junction protein zonula occludens-1 (ZO-1)) associates with the phosphatase activity, membrane association and stability of PTEN. There are two PDZ-binding domains and six phosphorylation sites in the C-terminal tail, including threonine 366 (Thr366), serine 370 (Ser370), Ser380, Thr382, Thr383 and Ser385 [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR11">11</xref>] (Fig. <xref ref-type="fig" rid="Fig1">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>The Structure of PTEN. PTEN encodes a 403-amino acid peptide, which is composed of a phosphatidylinositol-4, 5-bisphosphate-binding domain (PBD) (residues 1–13), a catalytic phosphatase domain (PD) (residues 14–185), a C2 membrane binding domain (C2D)(residues 186–350), and a C-terminal tail (residues 351–403). The PD includes a conserved catalytic motif HCKAGKGR. The C2 domain includes two tyrosine phosphorylation sites (Y240 and Y315). There are two PDZ-binding domains (PDZ-BD) and six phosphorylation sites in the C-terminal tail. PDZ, post-synaptic density protein (PSD95), Drosophila discs large (Dlg) and the tight junction protein zonula occludens-1 (ZO-1)</p></caption><graphic id="MO1" xlink:href="13046_2018_898_Fig1_HTML"></graphic></fig></p>
<p id="Par50">PTEN contributes to the control of several important cellular signaling pathways. PTEN dephosphorylates phosphatidylinositol (3,4,5)-triphosphate (PIP3), therefore represses the activation of phosphatidylinositol-3-kinase (PI3K)/Akt and the mammalian target of rapamycin (mTOR) signaling pathway, Akt/ glycogen synthase kinase3(GSK-3)/Snail signaling pathway, or Akt/GSK-3/Wnt/ signaling pathway. Furthermore, GSK-3 interacts with and phosphorylates PTEN, which contributes to the inactivation of PTEN. Focal adhesion kinase (FAK) is dephosphorylated by PTEN directly, leading to the inactivation of FAK/p130Cas pathway. PTEN also dephosphorylates Src homology 2-containing protein (Shc) directly, and inhibits the activation of Shc/Raf/ERK1/2 (extracellular signal-regulated kinase) signaling cascade. Through controlling these pathways, PTEN ultimately represses cell survival, proliferation, metastasis and so on [<xref ref-type="bibr" rid="CR12">12</xref>–<xref ref-type="bibr" rid="CR18">18</xref>] (Fig. <xref ref-type="fig" rid="Fig2">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>The schematic representation of the major signaling pathways in which PTEN is involved. CK2, casein kinase II; PDZK1, PDZ-containing 1; GSK3, Glycogen synthase kinase3; FAK, Focal adhesion kinase; Rac, Ras-related C3 botulinum toxin substrate; SHC, Src homology 2-containing protein; MEK, MAPKK(mitogen-activated protein kinase kinase); ERK1/2, Extracellular signal-related kinase 1/2; PIP3, Phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)<italic>P</italic><sub>3</sub>); Akt, Protein kinase B (PKB); MDM2, Mouse double minute 2 homolog; TSC2, Tuberous Sclerosis Complex 2; mTORC, Mammalian target of rapamycin complex; CSCs, Cancer stem cells</p></caption><graphic id="MO2" xlink:href="13046_2018_898_Fig2_HTML"></graphic></fig></p>
<p id="Par51">PTEN expression alteration is crucial to the pathogenesis of cancer and other diseases. Low level of PTEN caused by homozygous deletions, frameshift, nonsense mutations or hypermethylation of the gene or destability of the protein occurs frequently in various human cancers [<xref ref-type="bibr" rid="CR19">19</xref>–<xref ref-type="bibr" rid="CR23">23</xref>] and <italic>PTEN</italic> depletion in mice leads to a substantial rise in tumorigenesis [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. <italic>PTEN</italic> mutations were reported as a cause of obesity and autism spectrum disorders [<xref ref-type="bibr" rid="CR26">26</xref>–<xref ref-type="bibr" rid="CR28">28</xref>]. PTEN protein level was decreased in an OVA-induced-asthma mouse model, and the administration of PTEN expressing adenovirus remarkably reduced bronchial inflammation and airway hyperresponsiveness [<xref ref-type="bibr" rid="CR29">29</xref>]. However, high level of PTEN either contributes to pathological processes. Elevated PTEN expression was observed in endothelium of atherosclerotic brachial arteries from hemodialysis patients. PTEN overexpression stimulated the thrombosis formation of arteriovenous graft by inducing endothelial dysfunction [<xref ref-type="bibr" rid="CR30">30</xref>]. PTEN negatively regulates neuron survival, and PTEN downregulation showed neuroprotective effects in mouse models of neuron death and Parkinson’s disease [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. Inhibition of PTEN rescued synaptic function and cognition in cellular and animal models of Alzheimer’s disease, whereas <italic>PTEN</italic> transgenic mice displayed synaptic depression [<xref ref-type="bibr" rid="CR33">33</xref>]. In brief, abnormal PTEN expression level is associated to multiple diseases. Understanding the regulation mechanisms of PTEN expression and maintaining the homeostasis of PTEN should be beneficial.</p>
<p id="Par52">The expression and activity of PTEN is modulated by several upstream molecules. P53 binds <italic>PTEN</italic> promoter and induces its transcription [<xref ref-type="bibr" rid="CR34">34</xref>]. PDZK1 (PDZ-containing 1) induces PTEN dephosphorylation through binding the PDZ-binding domain in the PTEN C-terminal domain, which promotes the anti-oncogenic function of PTEN. Protein kinase CK2 (formerly casein kinase II) interacts with and phosphorylates PTEN C-terminal tail, which contributes to maintain PTEN stability [<xref ref-type="bibr" rid="CR35">35</xref>]. Src inhibits PTEN activity to promote the post-ischaemic contractile recovery in apelin-induced cardioprotection [<xref ref-type="bibr" rid="CR36">36</xref>]. Recently, with the development of the study on noncoding RNAs (ncRNAs), the control of PTEN expression by ncRNAs attracted more attention. Herein, we focus on the regulation of PTEN expression by ncRNAs, which is supposed to provide a reference for the coming laboratory and clinical studies on PTEN regulation (Fig. <xref ref-type="fig" rid="Fig3">3</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>The regulation of PTEN expression. PTEN expression is dynamically regulated by various events, including genomic mutation or deletion, transcriptional, epigenetic, posttranscriptional, and posttranslational modulation. Noncoding RNAs epigenetically or posttranscriptionally regulate PTEN expression</p></caption><graphic id="MO3" xlink:href="13046_2018_898_Fig3_HTML"></graphic></fig></p>
<p id="Par53">More than 98% DNAs that do not encode proteins are called ncRNAs [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. In general, ncRNAs are classified into two groups as small ncRNAs (≤ 200 nt) and long ncRNAs (lncRNAs) (&gt; 200 nt). MicroRNAs (miRNAs) (~ 18 to 24 nt) are an important group of small ncRNAs, which epigenetically or posttranscriptionally control the expression of the target mRNAs by pairing to them, leading to the alteration of transcription, mRNA stability or translation [<xref ref-type="bibr" rid="CR39">39</xref>–<xref ref-type="bibr" rid="CR42">42</xref>]. LncRNAs take up a great proportion in the “transcriptome”, which play vital gene regulatory roles in the chromatin modification, transcriptional regulation, posttranscriptional regulation and so on [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. Emerging evidence indicates that PTEN functions in a dosage-dependent manner during tumor development [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. NcRNAs are key regulators of PTEN dosage, including miRNAs and lncRNAs, which delicately modulate the PTEN expression (Tables <xref ref-type="table" rid="Tab1">1</xref> and <xref ref-type="table" rid="Tab2">2</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Regulation of PTEN expression by miRNAs</p></caption><table frame="hsides" rules="groups"><thead><tr><th>MiRNA</th><th>PTEN expression</th><th>Mechanism</th><th>Disease</th><th>Reference</th></tr></thead><tbody><tr><td>miR-21</td><td>Down</td><td>directly targeting PTEN mRNA</td><td>Gastric cancer, HNSCC, CCRCC</td><td>[<xref ref-type="bibr" rid="CR52">52</xref>–<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td>miR-130</td><td>Down</td><td>directly targeting PTEN mRNA</td><td>Bladder cancer, Breast invasive carcinoma, HCAECs injury, Inflammatory responses, PD, Lung adenocarcinoma, Colon adenocarcinoma</td><td>[<xref ref-type="bibr" rid="CR55">55</xref>–<xref ref-type="bibr" rid="CR58">58</xref>]</td></tr><tr><td>miR-130</td><td>Up</td><td>directly targeting PTEN mRNA</td><td>NSCLC</td><td>[<xref ref-type="bibr" rid="CR59">59</xref>]</td></tr><tr><td>miR-451</td><td>Up</td><td>directly targeting PTEN mRNA</td><td>Lung cancer, Ovarian cancer</td><td>[<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]</td></tr><tr><td>miR-221 /222</td><td>Down</td><td>directly targeting PTEN mRNA</td><td>NSCLC,HCC, TRAIL-induced cell death</td><td>[<xref ref-type="bibr" rid="CR62">62</xref>]</td></tr><tr><td>miR-301a</td><td>Down</td><td>directly targeting PTEN mRNA</td><td>Breast cancer, Neuronal death, Ewing’s carcoma, Melanoma, Insulin resistance</td><td>[<xref ref-type="bibr" rid="CR63">63</xref>–<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr><tr><td>miR-214</td><td>Down</td><td>directly targeting PTEN mRNA</td><td>Tumorigenesis, Immunology, Cardiac injury</td><td>[<xref ref-type="bibr" rid="CR68">68</xref>–<xref ref-type="bibr" rid="CR71">71</xref>]</td></tr><tr><td>miR-494</td><td>Down</td><td>directly targeting PTEN mRNA</td><td>Ischemia/Reperfusion -induced myocardial injury</td><td>[<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>]</td></tr><tr><td>miR-155-5p/130b/616/19/92a/10a/106a/429/26a /486-5p</td><td>Down</td><td>directly targeting PTEN mRNA</td><td>HCC, NSCLC, Breast cancer, Lung cancer, Colorectal Cancer, Chronic myeloid leukemia, Intestinal cancer, Acute T-cell lymphoblastic leukemia</td><td>[<xref ref-type="bibr" rid="CR74">74</xref>–<xref ref-type="bibr" rid="CR84">84</xref>]</td></tr><tr><td>miR-29</td><td>Up</td><td>inducing the hypomethylation of PTEN promoter by inhibiting DNMT1, DNMT3b and SET1A expression</td><td>Liver fibrosis</td><td>[<xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR88">88</xref>]</td></tr><tr><td>miR-101</td><td>Up</td><td>inducing the hypomethylation of PTEN promoter by inhibiting DNMT3A expression</td><td>Lung cancer</td><td>[<xref ref-type="bibr" rid="CR89">89</xref>, <xref ref-type="bibr" rid="CR90">90</xref>]</td></tr><tr><td>miR-185</td><td>Up</td><td>inducing the hypomethylation of PTEN promoter by inhibiting DNMT1 expression</td><td>HCC</td><td>[<xref ref-type="bibr" rid="CR91">91</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>Regulation of PTEN expression by lncRNAs</p></caption><table frame="hsides" rules="groups"><thead><tr><th>LncRNA</th><th>PTEN expression</th><th>Mechanism</th><th>MiRNA</th><th>Disease</th><th>Reference</th></tr></thead><tbody><tr><td>PTENP1</td><td>Up</td><td>acting as ceRNAs</td><td>miR-21, miR-17, miR-214, miR-19, miR-20, miR-93, miR-106b, miR-26</td><td>CCRCC, OSCC, HCC, Gastric cancer</td><td>[<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR96">96</xref>–<xref ref-type="bibr" rid="CR101">101</xref>]</td></tr><tr><td>HOTAIR</td><td>Up</td><td>acting as ceRNAs</td><td>miR-19</td><td>Cardiac hypertrophy</td><td>[<xref ref-type="bibr" rid="CR105">105</xref>]</td></tr><tr><td>Linc-USP16</td><td>Up</td><td>acting as ceRNAs</td><td>miR-21,miR-590-5p</td><td>HCC</td><td>[<xref ref-type="bibr" rid="CR106">106</xref>]</td></tr><tr><td>LncRNA-BGL3</td><td>Up</td><td>acting as ceRNAs</td><td>miR-17, miR-20a, miR-20b, miR-93, miR-106a</td><td>Chronic myeloid leukemia</td><td>[<xref ref-type="bibr" rid="CR80">80</xref>]</td></tr><tr><td>CASC2</td><td>Up</td><td>acting as both ceRNAs and downregulators of miRNAs</td><td>miR-21, miR-181a</td><td>Osteosarcoma, Glioma, Cervical cancer</td><td>[<xref ref-type="bibr" rid="CR107">107</xref>–<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td>MEG3</td><td>Up</td><td>acting as both ceRNAs and downregulators of miRNAs</td><td>miR-1297, miR-19a, miR-21</td><td>Breast cancer, Glioma, CAD</td><td>[<xref ref-type="bibr" rid="CR111">111</xref>–<xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td>lncRNA GAS5</td><td>Up</td><td>acting as both ceRNAs and downregulators of miRNAs</td><td>miR-21, miR-103, miR-196a, miR-205, miR-32-5p</td><td>HER2-positive breast cancer, HCC, NSCLC, Cardiac fibrosis, Endometrial cancer, Cervical cancer, Pancreatic cancer</td><td>[<xref ref-type="bibr" rid="CR114">114</xref>–<xref ref-type="bibr" rid="CR120">120</xref>]</td></tr><tr><td>XIST</td><td>Up</td><td>acting as both ceRNAs and downregulators of miRNAs</td><td>miR-181a, MiR-494</td><td>HCC, Spinal Cord Injury</td><td>[<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR122">122</xref>]</td></tr><tr><td>NBAT1</td><td>Up</td><td>acting as both ceRNAs and downregulators of miRNAs</td><td>miR-21</td><td>Osteosarcoma</td><td>[<xref ref-type="bibr" rid="CR123">123</xref>]</td></tr><tr><td>lnc-2 /lnc-6</td><td>Up</td><td>acting as both ceRNAs and downregulators of miRNAs</td><td>miR-26a</td><td>Prostate cancer, Glioma</td><td>[<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR127">127</xref>]</td></tr><tr><td>FER1L4</td><td>Up</td><td>acting as both ceRNAs and downregulators of miRNAs</td><td>miR-106a-5p</td><td>Colon cancer, Gastric cancer</td><td>[<xref ref-type="bibr" rid="CR130">130</xref>, <xref ref-type="bibr" rid="CR131">131</xref>]</td></tr><tr><td>lincRNA-p21</td><td>Up</td><td>acting as both ceRNAs and downregulators of miRNAs</td><td>miR-181b</td><td>Liver fibrosis</td><td>[<xref ref-type="bibr" rid="CR132">132</xref>]</td></tr><tr><td>PTENP1 asRNA β</td><td>Up</td><td>increasing the stability and miRNA sponge activity of PTENP1</td><td>–</td><td>–</td><td>[<xref ref-type="bibr" rid="CR133">133</xref>]</td></tr><tr><td>HOTAIR</td><td>Down</td><td>enhancing PTEN methylation via miRNA sponging</td><td>miR-29b</td><td>Liver Fibrosis, LSCC</td><td>[<xref ref-type="bibr" rid="CR134">134</xref>, <xref ref-type="bibr" rid="CR135">135</xref>]</td></tr><tr><td>PTENP1 asRNA α</td><td>Down</td><td>enhancing PTEN methylation via the recruitment of DNMT3a and EZH2</td><td>–</td><td>–</td><td>[<xref ref-type="bibr" rid="CR133">133</xref>]</td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="Sec2">
<title>MiRNAs modulate PTEN expression</title>
<sec id="Sec3">
<title>Altering PTEN expression by directly targeting PTEN mRNA</title>
<p id="Par54">MiR-21 is one of the first identified mammalian microRNAs. The human <italic>miR-21</italic> gene is located at chromosome 17q23.2 within a coding gene <italic>TMEM49</italic> (also called vacuole membrane protein), which is highly conserved [<xref ref-type="bibr" rid="CR46">46</xref>]. Early lineage tracing studies demonstrated that miR-21 was upregulated in various diseases, including acute pancreatitis [<xref ref-type="bibr" rid="CR47">47</xref>], Myelodysplastic syndromes [<xref ref-type="bibr" rid="CR48">48</xref>], severe steroid-insensitive allergic airway disease [<xref ref-type="bibr" rid="CR49">49</xref>], liver cancer [<xref ref-type="bibr" rid="CR50">50</xref>] and lung cancer [<xref ref-type="bibr" rid="CR51">51</xref>].</p>
<p id="Par55">PTEN is one of the important targets negatively regulated by miR-21. The 3′UTR of human PTEN contains a putative region that is able to pair to the seed sequence of miR-21 (Fig. <xref ref-type="fig" rid="Fig4">4</xref>). The exosomal miR-21 transferred from macrophages downregulated the PTEN level in gastric cancer cells, which resulted in the suppression of cell apoptosis and activation of PI3K/AKT signaling pathway [<xref ref-type="bibr" rid="CR52">52</xref>]. Inhibition of miR-21 reversed EMT by increasing PTEN protein level in head and neck squamous cell carcinoma (HNSCC), resulting in the suppression of cell proliferation and motility [<xref ref-type="bibr" rid="CR53">53</xref>]. MiR-21 was able to directly target the 3′UTR of PTEN, increasing clear-cell renal cell carcinoma (CCRCC) cell migration, invasion both in vitro and in vivo [<xref ref-type="bibr" rid="CR54">54</xref>].<fig id="Fig4"><label>Fig. 4</label><caption><p>A Predicted miR-21 binding site within the 3’UTR of PTEN mRNA. By Target Scan Human Release 7.0 (<ext-link ext-link-type="uri" xlink:href="http://www.targetscan.org">http://www.targetscan.org</ext-link>)</p></caption><graphic id="MO4" xlink:href="13046_2018_898_Fig4_HTML"></graphic></fig></p>
<p id="Par56">Expression of miR-130 family members has been recently reported to be correlated inversely to PTEN expression in bladder cancer, breast invasive carcinoma, lung adenocarcinoma and colon adenocarcinoma [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. Overexpression of miR-130a increased cell proliferation and motility via repression of PTEN expression, associated with the upregulation of FAK and Akt phosphorylation [<xref ref-type="bibr" rid="CR55">55</xref>–<xref ref-type="bibr" rid="CR57">57</xref>]. MiR-130a decreases the PTEN level to activate PI3K/Akt/eNOS (endothelial nitric oxide synthase) signaling pathway, promoting human coronary artery endothelial cells (HCAECs) injury and inflammatory responses [<xref ref-type="bibr" rid="CR57">57</xref>]. Exogenous expression of miR-130a prevented midbrain dopaminergic (mDA) neuron degeneration in Parkinson’s disease (PD) by suppressing the synthesis of PTEN [<xref ref-type="bibr" rid="CR58">58</xref>].</p>
<p id="Par57">Controversially, miR-130 was also found to be downregulated and positively correlated to PTEN levels in non-small cell lung cancer (NSCLC) tissue samples. The upregulation of miR-130 significantly increased PTEN expression, inhibited NSCLC cell growth and enhanced cell apoptosis both in <italic>vitro</italic> and in <italic>vivo</italic> [<xref ref-type="bibr" rid="CR59">59</xref>]. Even the same pairing sequence of miR-130 and PTEN 3’UTR were used, opposite results were obtained in dual luciferase reporter assays from two reports. The relative activity of the luciferase harboring PTEN 3’UTR was promoted in A549 cells but repressed in 293 T cells by miR-130 [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. Although the mechanisms remain obscure, a tissue-specific pattern is possible for the regulation of PTEN by miR-130. MiR-130 might regulate PTEN expression through different ways according to the cellular context. PTEN protein was found to be slightly increased after the pre-miR-451-transfection in lung cancer cells [<xref ref-type="bibr" rid="CR60">60</xref>]. Both miR-451 and PTEN expression level was reported to be significantly reduced in ovarian cancer [<xref ref-type="bibr" rid="CR61">61</xref>].</p>
<p id="Par58">Over the past decade, mountains of results show that the interaction of PTEN with miRNAs related to different diseases. MiR-221 and miR-222 were reported to be upregulated in aggressive NSCLC and hepatocarcinoma (HCC) cells, and conferred resistance to TNF-related apoptosis-inducing ligand (TRAIL)-induced cell death by targeting PTEN [<xref ref-type="bibr" rid="CR62">62</xref>]. MiR-301a mediates the tumorigenesis of breast cancer, Ewing’s carcoma and melanoma, prevents neuronal death, and contributes to insulin resistance via decreasing PTEN protein level [<xref ref-type="bibr" rid="CR63">63</xref>–<xref ref-type="bibr" rid="CR67">67</xref>]. MiR-214 induces tumorigenesis, stimulates immunology, and protects cardiac injury through inhibiting PTEN expression [<xref ref-type="bibr" rid="CR68">68</xref>–<xref ref-type="bibr" rid="CR71">71</xref>]. MiR-494 targets PTEN and activates Akt pathway, leading to protect against ischemia/reperfusion -induced myocardial injury [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>]. There are also many other miRNAs directly targeting PTEN, such as miR-155-5p [<xref ref-type="bibr" rid="CR74">74</xref>], miR-130b [<xref ref-type="bibr" rid="CR75">75</xref>], miR-616 [<xref ref-type="bibr" rid="CR76">76</xref>], miR-19 [<xref ref-type="bibr" rid="CR77">77</xref>], miR-92a [<xref ref-type="bibr" rid="CR78">78</xref>], miR-10a [<xref ref-type="bibr" rid="CR79">79</xref>], miR-106a [<xref ref-type="bibr" rid="CR80">80</xref>], miR-429 [<xref ref-type="bibr" rid="CR81">81</xref>], miR-26a [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>] and miR-486-5p [<xref ref-type="bibr" rid="CR84">84</xref>]. Consistent with miR-21, these miRNAs directly bind to the 3′UTR of human PTEN, and inhibit PTEN expression.</p>
</sec>
<sec id="Sec4">
<title>Upregulating PTEN expression by targeting DNA methyltransferases (DNMTs)</title>
<p id="Par59">DNA methyltransferases (DNMTs) are the enzymes for DNA methylation, transferring a methyl group to the cytosine residues of DNA. DNA methylation of a gene promoter typically represses the gene transcription. The promoter region of the <italic>PTEN</italic> gene consists of three methylation sites. Overexpression of DNMT1 led to PTEN downregulation due to the CpG island methylation in promoter, which promoted tumorigenesis of breast cancer, ovarian cancer and acute myeloid leukemia (AML) [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR86">86</xref>]. MiRNAs targeting DNMTs increase the PTEN expression. MiR-29a was found to inhibit DNMT1, DNMT3b and SET domain containing 1A (SET1A) expression, resulting in elevated PTEN expression and decreased offibrogenic activities in hepatic stellate cells (HSCs) [<xref ref-type="bibr" rid="CR87">87</xref>]. Curcumin treatment suppressed liver fibrosis by inducing miR-29b expression in HSCs, which led to the low expression of DNMT3b and PTEN hypomethylation [<xref ref-type="bibr" rid="CR88">88</xref>] (Fig. <xref ref-type="fig" rid="Fig5">5</xref>). Bioinformatics and dual luciferase reporter assays demonstrated that DNMT3A is a target of miR-101 [<xref ref-type="bibr" rid="CR89">89</xref>]. Introduction of miR-101 inhibitor increased the protein level of DNMT3A instead of the mRNA expression. Overexpression of miR-101 or silencing of DNMT3A induced the hypomethylation of <italic>PTEN</italic> promoter which was verified by a methylation specific PCR assay [<xref ref-type="bibr" rid="CR90">90</xref>]. The expression of miR-185 was inhibited in cultured human HCC cells [<xref ref-type="bibr" rid="CR91">91</xref>]. Introduction of miR-185 mimics significantly reduced DNMT1 expression, decreased <italic>PTEN</italic> promoter methylation and increased the protein level of PTEN. MiR-185 overexpression decreased the reporter activity of the luciferase with DNMT1 3’UTR, and forced expression of DNMT1 reversed the loss of <italic>PTEN</italic> promoter methylation mediated by miR-185.<fig id="Fig5"><label>Fig. 5</label><caption><p>MiR-29a upregulates PTEN expression by targeting DNMTs. MiR-29a could repress DNMTs at posttranscriptional level, resulting in a decrease of CpG island methylation of the PTEN promoter. DNMTs, DNA methyltransferases</p></caption><graphic id="MO5" xlink:href="13046_2018_898_Fig5_HTML"></graphic></fig></p>
</sec>
</sec>
<sec id="Sec5">
<title>LncRNAs modulate PTEN expression indirectly</title>
<p id="Par60">LncRNAs have multiple important functions in cellular and developmental processes. LncRNAs may carry out both gene inhibition and activation through diverse mechanisms [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. The studies on the lncRNAs associated with PTEN suggest that lncRNAs modulate PTEN expression by altering either the related miRNAs or promoter methylation.</p>
<sec id="Sec6">
<title>Acting as competing endogenous RNAs (ceRNAs)</title>
<p id="Par61">LncRNAs can act as competing endogenous RNAs (ceRNAs) to indirectly regulate mRNAs through the shared miRNAs. LncRNAs compete the seed sites of miRNAs with their target mRNAs, leading to block the effects of miRNAs on the mRNA targets [<xref ref-type="bibr" rid="CR92">92</xref>–<xref ref-type="bibr" rid="CR95">95</xref>].</p>
<p id="Par62"><italic>PTENP1</italic>, located on chromosome 9p21, is a highly conserved pseudogene of <italic>PTEN</italic>. Gan Yu et al. reported the low expression of PTENP1 due to methylation in CCRCC tissues and cell lines. Both PTEN and PTENP1 expression is inversely correlated with miR-21 expression. In miR-21 overexpressing cells, PTENP1 introduction suppressed cell proliferation and metastasis, and increased the cell sensitivity to cisplatin and gemcitabine, restoring the phenotypes induced by PTEN in vitro and in vivo [<xref ref-type="bibr" rid="CR54">54</xref>]. Activation of PTENP1 partially inhibited the suppression of PTEN by miR-21 in oral squamous cell carcinoma (OSCC) tumor xenografts [<xref ref-type="bibr" rid="CR96">96</xref>]. Evidences have revealed that PTENP1 expression level is positively related to PTEN transcript, and PTENP1 protects PTEN mRNA through serving as a decoy for miRNAs, such as miR-21, miR-17, miR-214, miR-19, miR-20, miR-93, miR-106b and miR-26 families [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR97">97</xref>–<xref ref-type="bibr" rid="CR101">101</xref>] (Fig. <xref ref-type="fig" rid="Fig6">6</xref>).<fig id="Fig6"><label>Fig. 6</label><caption><p>PTENP1 works as a ceRNA to promote PTEN expression. PTENP1 recruits miRNAs such as miR-181a and miR-21, therefore impairs the miRNAs binding PTEN</p></caption><graphic id="MO6" xlink:href="13046_2018_898_Fig6_HTML"></graphic></fig></p>
<p id="Par63">Homeobox (HOX) transcript antisense RNA (HOTAIR) is encoded within the <italic>HoxC</italic> gene cluster on chromosome 12, which silences the expression of <italic>HoxD</italic> genes and numerous tumor and metastasis suppressors [<xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR103">103</xref>] by interacting with chromatin-remodeling enzymes [<xref ref-type="bibr" rid="CR104">104</xref>]. On the contrary, HOTAIR regulates PTEN expression as a ceRNA. HOTAIR expression decreased notably in sustained cardiac hypertrophy mouse models, in which miR-19 expression was increased and inversely correlated with HOTAIR expression. HOTAIR has a binding site for miR-19 seed sequence, and HOTAIR overexpression restored the inhibition of luciferase activity with PTEN 3’UTR mediated by miR-19 [<xref ref-type="bibr" rid="CR105">105</xref>].</p>
<p id="Par64">Linc-USP16 acted as a ceRNA for miR-21 and miR-590-5p, promoting PTEN expression to repress the growth and stimulate apoptosis in HCC in vivo and in vitro [<xref ref-type="bibr" rid="CR106">106</xref>]. LncRNA-BGL3 worked as a ceRNA for miR-17, miR-93, miR-20a, miR-20b, miR-106a and miR-106b, rescuing the repression of PTEN expression to inhibit Bcr-Abl-induced cellular transformation [<xref ref-type="bibr" rid="CR80">80</xref>].</p>
</sec>
<sec id="Sec7">
<title>Acting as both ceRNAs and downregulators of miRNAs</title>
<p id="Par65">LncRNAs can also decrease the expression level of miRNA as well as being sponges, leading to suppress the effects of miRNAs on their mRNA targets.</p>
<p id="Par66"><italic>Cancer susceptibility candidate 2 (CASC2)</italic>, mapped to chromosome 10q26, encodes a lncRNA which acts as a ceRNA of miR-21 or miR-181a and exerts biological effects by increasing the expression of PTEN [<xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR108">108</xref>]. The expression of CASC2 is significantly downregulated in glioma, osteosarcoma or cervical cancer tissues and cell lines, and CASC2 expression level is negatively correlated to miR-181a level in glioma tissues. CASC2 overexpression significantly repressed cell proliferation, and amplified temozolomide- or cisplatin-induced repression of cell proliferation in vitro, which was associated with the downregulation of miR-181a and miR-21. CASC2 overexpression upregulated PTEN level, which was partially restored by miR-181a and miR-21 mimics. In addition, CASC2 was found to interact directly with miR-181a and miR-21 in dual-luciferase reporter assays [<xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR109">109</xref>].</p>
<p id="Par67"><italic>Maternally expressed gene 3 (MEG3)</italic>, encoding a lncRNA, is located at the chromosome 14q32. In testicular germ cell tumor (TGCT) tissues, lncRNA MEG3 level is significantly decreased, while PTEN protein but not mRNA levels are notably downregulated [<xref ref-type="bibr" rid="CR110">110</xref>]. Bioinformatics analyses showed that miR-1297 bound not only 3’UTR of PTEN mRNA but also MEG3 [<xref ref-type="bibr" rid="CR111">111</xref>]. MEG3 overexpression disturbed the binding of miR-1297 to 3’UTR of PTEN mRNA and remitted the reduction of PTEN induced by miR-1297. MEG3 downregulation and miR-19a upregulation were reported in malignant glioma tissues and cell lines, and luciferase results verified the complementary binding between miR-19a and MEG3. MiR-19a overexpression repressed the expression of PTEN and promoted glioma cell proliferation, migration, and invasion [<xref ref-type="bibr" rid="CR112">112</xref>]. Moreover, in the coronary artery disease (CAD) tissues, MEG3 level declines, and miR-21 expression has negative correlation with MEG3 expression. Overexpression of MEG3 suppressed miR-21 expression, promoted the expression of PTEN, and suppressed the proliferation of endothelial cells [<xref ref-type="bibr" rid="CR113">113</xref>].</p>
<p id="Par68">LncRNA growth arrest specific transcript 5 (lncRNA GAS5) is downregulated in NSCLC, breast cancer and HCC tissues, and lncRNA GAS5 knockdown repressed cell viability. lncRNA GAS5 competes with PTEN to bind miR-21, and depletion or overexpression of lncRNA GAS5 could increase or decrease miR-21 expression, resulting in the downregulation or upregulation of PTEN level in these tumor cells [<xref ref-type="bibr" rid="CR114">114</xref>–<xref ref-type="bibr" rid="CR116">116</xref>]. A low expression of lncRNA GAS5 and an upregulation of miR-21 are reported in cardiac fibrosis. The downregulation of PTEN expression mediated by miR-21 mimics was reversed by overexpressing lncRNA GAS5 in cardiac fibroblast cells [<xref ref-type="bibr" rid="CR117">117</xref>]. LncRNA GAS5 could also induce PTEN expression by inhibiting miR-103 [<xref ref-type="bibr" rid="CR118">118</xref>], miR-196a and miR-205 [<xref ref-type="bibr" rid="CR119">119</xref>], and miR-32-5p [<xref ref-type="bibr" rid="CR120">120</xref>].</p>
<p id="Par69">The lncRNA X inactivate-specific transcript (XIST) directly interacts with miR-181a, and they repress the expression of each other. XIST overexpression restored the PTEN downregulation induced by miR-181a mimics, and transfection with XIST siRNA significantly enhanced the proliferation and invasion of liver cancer cells together with a decreased PTEN level [<xref ref-type="bibr" rid="CR121">121</xref>]. Neuronal apoptosis and lncRNA XIST expression level were found to be promoted in an spinal cord injury model. XIST acts as a sink for miR-494, leading to derepression of PTEN. MiR-494 expression was upregulated with XIST knockdown, whereas was downregulated with XIST overexpression. AntagomiR-494 treatment reversed the protective effects of XIST depletion on spinal cord injury through blocking the PTEN/PI3K/AKT signaling pathway [<xref ref-type="bibr" rid="CR122">122</xref>].</p>
<p id="Par70">The low expression of LncRNA neuroblastoma associated transcript 1 (NBAT1) in osteosarcoma tissues and cells was closely correlated to clinical stages, lymph node metastasis and poor prognosis [<xref ref-type="bibr" rid="CR123">123</xref>]. NBAT1 binds miR-21, and suppresses miR-21 expression. NBAT1 overexpression downregulated osteosarcoma growth and metastasis via acting as a ceRNA against miR-21, which was associated with PTEN upregulation in vitro and in vivo.</p>
<p id="Par71">The expression of lnc-2 and lnc-6 showed positive correlation with PTEN in prostate cancer cohorts [<xref ref-type="bibr" rid="CR124">124</xref>, <xref ref-type="bibr" rid="CR125">125</xref>]. Knockdown of lnc-2 or lnc-6 led to a significant decrease in PTEN expression at both protein and mRNA levels and a significant increase in cell proliferation. On the contrary, depletion of PTEN reduced the expression of both lnc-2 and lnc-6,and the reduction of PTEN expression by overexpressing known PTEN-regulating miRNAs could be rescued by overexpressing lnc-2 sub-sequences [<xref ref-type="bibr" rid="CR126">126</xref>]. PTEN and lnc-6 are downregulated while miR-26a is upregulated in human glioma. Lnc-6 introduction into glioma cells resulted in a decrease of miR-26a expression [<xref ref-type="bibr" rid="CR127">127</xref>].</p>
<p id="Par72">Microarray and real time PCR results showed that lncRNA fer-1-like family member 4 (FER1L4) was downregulated in gastric cancer, endometrial carcinoma and colon cancer tissues or cell lines [<xref ref-type="bibr" rid="CR128">128</xref>]. Enforced expression of FER1L4 increased PTEN expression at both mRNA and protein levels, which might contribute to cell cycle arrest and apoptosis [<xref ref-type="bibr" rid="CR129">129</xref>]. In colon cancer cell lines, FER1L4 expression is inversely correlated with miR-106a-5p expression [<xref ref-type="bibr" rid="CR130">130</xref>]. Luciferase assay results suggested direct interactions between miR-106a-5p and FER1L4 or PTEN. Knockdown of FER1L4 increased miR-106a-5p expression level and decreased the levels of PTEN mRNA and protein [<xref ref-type="bibr" rid="CR130">130</xref>, <xref ref-type="bibr" rid="CR131">131</xref>].</p>
<p id="Par73">Fujun Yu et al. reported a novel lincRNA-p21-miR-181b-PTEN signaling cascade in liver fibrosis [<xref ref-type="bibr" rid="CR132">132</xref>]. LincRNA-p21 overexpression significantly suppressed the isolated rat HSC activation and the expression of extracellular matrix (ECM) proteins, which was reversed by depletion of PTEN. MiR-181b binds lincRNA-p21, and miR-181b level was reduced by exogenous lincRNA-p21, while the effects of lincRNA-p21 on PTEN expression and HSC activation were inhibited by miR-181b mimics.</p>
</sec>
<sec id="Sec8">
<title>Increasing the stability of lncRNAs</title>
<p id="Par74"><italic>PTENP1</italic>, also encodes antisense RNAs (asRNAs), which has two isoforms, α and β. PTENP1 asRNA β interacts with PTENP1 through an RNA:RNA pairing interaction, and the stability of PTENP1 was decreased when the interaction was interfering using U6 encoded ssRNAs or PTENP1 asRNA β was knocked down. Thus PTENP1 asRNA β upregualtes PTEN level via increasing the stability and miRNA sponge activity of PTENP1 [<xref ref-type="bibr" rid="CR133">133</xref>].</p>
</sec>
<sec id="Sec9">
<title>Prompting the methylation of PTEN promoter</title>
<p id="Par75">HOTAIR expression is upregulated in HSCs during liver fibrosis. HOTAIR knockdown suppressed HSC proliferation and activation in vitro and in vivo, increasing PTEN level, with the loss of DNA methylation mediated by miR-29b [<xref ref-type="bibr" rid="CR134">134</xref>]. HOTAIR levels were significantly higher in human laryngeal squamous cell cancer (LSCC), and bisulfite sequencing of the PTEN promoter addressed that PTEN CpG islands were unmethylated in HOTAIR siRNA-transduced cells and PTEN methylation was significantly reduced [<xref ref-type="bibr" rid="CR135">135</xref>]. Collectively, HOTAIR might contribute to PTEN promoter methylation via sponging miR-29b.</p>
<p id="Par76">The expression of PTEN and PTENP1 asRNA α is negatively correlated in cell lines, and the α depletion resulted in the increase of PTEN transcript. PTENP1 asRNA α binds the PTEN promoter, and epigenetically downregulates PTEN transcription by the recruitment of DNMT3a and Enhancer of zeste homolog 2 (EZH2) to enhance the methylation of PTEN promoter. PTENP1 asRNA α knockdown induces cell cycle arrest and sensitizes cells to doxorubicin, suggesting the biological function for the PTENP1 asRNAs [<xref ref-type="bibr" rid="CR133">133</xref>, <xref ref-type="bibr" rid="CR136">136</xref>].</p>
</sec>
</sec>
<sec id="Sec10">
<title>Conclusions and future directions</title>
<p id="Par77">Due to the essential physiological function of PTEN, the ncRNAs controlling PTEN expression play crucial roles in various biological activation, such as autophagy and cell stemness. PTEN induces autophagy through repressing PI3K/Akt pathway, while miR-21 elevation was found in human degenerative nucleus pulposus tissues, which inhibits autophagy and induces ECM degradation via repressing PTEN expression [<xref ref-type="bibr" rid="CR137">137</xref>]; Human aortic smooth muscle cell-derived exosomal miR-221/222 suppressed the autophagy in human umbilical vein endothelial cells by regulating PTEN/Akt signaling pathway in a co-culture system [<xref ref-type="bibr" rid="CR138">138</xref>]; MiR-21-5p significantly increases cell stemness of keloid keratinocytes, mediated by PTEN repression and AKT activation, which may account for the invasion and recurrence of keloids [<xref ref-type="bibr" rid="CR139">139</xref>]. MiR-10b promotes cellular self-renewal and expression of stemness markers in breast cancer stem cells through negative regulation of PTEN and sustained activation of AKT [<xref ref-type="bibr" rid="CR140">140</xref>].</p>
<p id="Par78">Actually, therapeutic strategies for multiple diseases focus on PI3K/Akt pathway inhibitors. However, the therapeutic benefit is modest due to the network complexities [<xref ref-type="bibr" rid="CR141">141</xref>, <xref ref-type="bibr" rid="CR142">142</xref>]. PTEN modulation has been considered as a possible approach to tumor and other diseases. NcRNAs including lncRNAs and miRNAs act alone or interact with each other to regulate PTEN expression. Elucidation of the details that ncRNAs modulate PTEN expression may provide novel insights into the regulation network of PTEN, which could suggest possible strategies to target PI3K/Akt pathway.</p>
<p id="Par79">Primary therapeutic attempts targeting ncRNAs to alter the PTEN expression have shown effects. Sophocarpine, a tetracyclic quinolizidine alkaloid derived from <italic>Sophora alopecuroides L</italic>, has shown inhibitory effects on HNSCC progression via the downregulation of miR-21 and the upregulation of PTEN in vivo and in vitro [<xref ref-type="bibr" rid="CR53">53</xref>]. Ursolic acid exerted protective action on high glucose-induced cell podocyte injury via decreasing miR-21 expression, which resulted in an increase of PTEN level [<xref ref-type="bibr" rid="CR143">143</xref>]. Combination of STAT3 inhibitor and DDP treatment led to a notable reduction of STAT3/miR-21 axis and an increase of PTEN level, repressing oral squamous cell carcinoma (OSCC) cell proliferation, migration and invasion [<xref ref-type="bibr" rid="CR144">144</xref>].</p>
<p id="Par80">As-miR-21 treatment presented an obvious inhibition on established glioma tumor growth and an increase in PTEN expresson. Coincidently, in a prostate xenograft model, injection of as-miR-4534 led to a significant reduction in tumor volume, which increased the expression level of PTEN [<xref ref-type="bibr" rid="CR145">145</xref>]. In a spontaneously developed lung tumors mouse model, treatment with the miR-214 antisense oligonucleotides microvesicles displayed promotion of PTEN levels and reduction of growth of spontaneous lung tumors [<xref ref-type="bibr" rid="CR68">68</xref>]. Furthermore, administration of LNA-antimiR-19a increased the sensitivity of multidrug resistant MCF-7 cells to Taxol in vivo, with an upregulation of PTEN verified [<xref ref-type="bibr" rid="CR146">146</xref>]. The growth of human LSCC xenograft was remarkably inhibited by HOTAIR shRNA lentivirus treatment [<xref ref-type="bibr" rid="CR135">135</xref>], and injection of the PTENP1-expressing baculovirus effectively mitigated the HCC xenograft tumor growth, which was associated with the increase of PTEN [<xref ref-type="bibr" rid="CR97">97</xref>].</p>
<p id="Par81">In term of the importance of PTEN expression level in physiological situation and pathogenesis of various diseases, modulating PTEN level could be considered as potential approaches for multiple diseases, while clarifying the regulation network of PTEN including ncRNAs is predicted to be able to provide novel strategies.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>AML</term>
<def>
<p id="Par2">Myeloid leukemia</p>
</def>
</def-item>
<def-item>
<term>C2D</term>
<def>
<p id="Par3">C2 membrane binding domain</p>
</def>
</def-item>
<def-item>
<term>CAD</term>
<def>
<p id="Par4">Coronary artery disease</p>
</def>
</def-item>
<def-item>
<term>CASC2</term>
<def>
<p id="Par5">Cancer susceptibility candidate 2</p>
</def>
</def-item>
<def-item>
<term>CCRCC</term>
<def>
<p id="Par6">Clear-cell renal cell carcinoma</p>
</def>
</def-item>
<def-item>
<term>ceRNAs</term>
<def>
<p id="Par7">Competing endogenous RNAs</p>
</def>
</def-item>
<def-item>
<term>CK2</term>
<def>
<p id="Par8">Formerly casein kinase II</p>
</def>
</def-item>
<def-item>
<term>CSCs</term>
<def>
<p id="Par9">Cancer stem cells</p>
</def>
</def-item>
<def-item>
<term>DNMTs</term>
<def>
<p id="Par10">DNA methyltransferases</p>
</def>
</def-item>
<def-item>
<term>ECM</term>
<def>
<p id="Par11">Extracellular matrix</p>
</def>
</def-item>
<def-item>
<term>EMT</term>
<def>
<p id="Par12">Mesenchymal transition</p>
</def>
</def-item>
<def-item>
<term>eNOS</term>
<def>
<p id="Par13">Endothelial nitric oxide synthase (eNOS)</p>
</def>
</def-item>
<def-item>
<term>ERK1/2</term>
<def>
<p id="Par14">Extracellular signal-regulated kinase</p>
</def>
</def-item>
<def-item>
<term>FAK</term>
<def>
<p id="Par15">Focal adhesion kinase</p>
</def>
</def-item>
<def-item>
<term>FER1L4</term>
<def>
<p id="Par16">lncRNA fer-1-like family member 4</p>
</def>
</def-item>
<def-item>
<term>GSK3</term>
<def>
<p id="Par17">Glycogen synthase kinase3</p>
</def>
</def-item>
<def-item>
<term>HCAECs</term>
<def>
<p id="Par18">Human coronary artery endothelial cells</p>
</def>
</def-item>
<def-item>
<term>HNSCC</term>
<def>
<p id="Par19">Head and neck squamous cell carcinoma</p>
</def>
</def-item>
<def-item>
<term>HOTAIR</term>
<def>
<p id="Par20">Homeobox (HOX) transcript antisense RNA</p>
</def>
</def-item>
<def-item>
<term>HSC</term>
<def>
<p id="Par21">Hepatic stellate cell</p>
</def>
</def-item>
<def-item>
<term>lncRNA GAS5</term>
<def>
<p id="Par22">lncRNA growth arrest specific transcript 5</p>
</def>
</def-item>
<def-item>
<term>lncRNAs</term>
<def>
<p id="Par23">Long ncRNAs</p>
</def>
</def-item>
<def-item>
<term>LSCC</term>
<def>
<p id="Par24">Laryngeal squamous cell cancer</p>
</def>
</def-item>
<def-item>
<term>mDA</term>
<def>
<p id="Par25">Midbrain dopaminergic</p>
</def>
</def-item>
<def-item>
<term>Meg3</term>
<def>
<p id="Par26">Maternally expressed gene 3</p>
</def>
</def-item>
<def-item>
<term>miRNAs</term>
<def>
<p id="Par27">Small ncRNAs</p>
</def>
</def-item>
<def-item>
<term>MMAC1</term>
<def>
<p id="Par28">Mutated in multiple advanced cancers</p>
</def>
</def-item>
<def-item>
<term>mTORC</term>
<def>
<p id="Par29">Mammalian target of rapamycin complex</p>
</def>
</def-item>
<def-item>
<term>NBAT1</term>
<def>
<p id="Par30">LncRNA neuroblastoma associated transcript 1</p>
</def>
</def-item>
<def-item>
<term>ncRNAs</term>
<def>
<p id="Par31">Noncoding RNAs</p>
</def>
</def-item>
<def-item>
<term>NSCLC</term>
<def>
<p id="Par32">Non-small cell lung cancer</p>
</def>
</def-item>
<def-item>
<term>OSCC</term>
<def>
<p id="Par33">Oral squamous cell carcinoma</p>
</def>
</def-item>
<def-item>
<term>PBD</term>
<def>
<p id="Par34">Phosphatidylinositol-4,5-bisphosphate-binding domain</p>
</def>
</def-item>
<def-item>
<term>PD</term>
<def>
<p id="Par35">A catalytic domain phosphatase domain</p>
</def>
</def-item>
<def-item>
<term>PD</term>
<def>
<p id="Par36">Parkinson’s disease</p>
</def>
</def-item>
<def-item>
<term>PDZ</term>
<def>
<p id="Par37">Post-synaptic density protein (PSD95), Drosophila discs large (Dlg) and the tight junction protein zonula occludens-1 (ZO-1)</p>
</def>
</def-item>
<def-item>
<term>PDZK1</term>
<def>
<p id="Par38">PDZ-containing 1</p>
</def>
</def-item>
<def-item>
<term>PI3K</term>
<def>
<p id="Par39">Phosphatidylinositol 3-kinase</p>
</def>
</def-item>
<def-item>
<term>PIP3</term>
<def>
<p id="Par40">Phosphatidylinositol (3,4,5)-triphosphate</p>
</def>
</def-item>
<def-item>
<term>PTEN</term>
<def>
<p id="Par41">Phosphatase and tensin homologue</p>
</def>
</def-item>
<def-item>
<term>PTENP1</term>
<def>
<p id="Par42">Pseudogene of PTEN</p>
</def>
</def-item>
<def-item>
<term>SET1A</term>
<def>
<p id="Par43">SET domain containing 1A</p>
</def>
</def-item>
<def-item>
<term>Shc</term>
<def>
<p id="Par44">Src homology 2-containing protein</p>
</def>
</def-item>
<def-item>
<term>TGCT</term>
<def>
<p id="Par45">Testicular germ cell tumor</p>
</def>
</def-item>
<def-item>
<term>TRAIL</term>
<def>
<p id="Par46">TNF-related apoptosis-inducing ligand</p>
</def>
</def-item>
<def-item>
<term>TSC2</term>
<def>
<p id="Par47">Tuberous Sclerosis Complex 2</p>
</def>
</def-item>
<def-item>
<term>XIST</term>
<def>
<p id="Par48">lncRNA X inactivate-specific transcript</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<title>Acknowledgements</title>
<p>This work was supported by Liaoning Provincial program for Top Discipline of Basic Medical Sciences. We thank all the members of Huang lab for kind support.</p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par82">This work was supported by the Climbing Scholars Supporting Program of Liaoning; and National Natural Science Foundation of China (81772971).</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>WL and LH designed and wrote the paper; WL, TZ, LG and LH collected and read the references, and made the figures. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar2">
<title>Ethics approval and consent to participate</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar3">
<title>Consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar4">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar5">
<title>Publisher’s Note</title>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steck</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Pershouse</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Jasser</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Yung</surname>
<given-names>WK</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ligon</surname>
<given-names>AH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers</article-title>
<source/>Nat Genet
          <year>1997</year>
<volume>15</volume>
<issue>4</issue>
<fpage>356</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="doi">10.1038/ng0497-356</pub-id>
<pub-id pub-id-type="pmid">9090379</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinde</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Maddika</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>PTEN regulates glucose transporter recycling by impairing SNX27 Retromer assembly</article-title>
<source/>Cell Rep
          <year>2017</year>
<volume>21</volume>
<issue>6</issue>
<fpage>1655</fpage>
<lpage>1666</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2017.10.053</pub-id>
<pub-id pub-id-type="pmid">29117568</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caserta</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Egriboz</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Koivisto</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pecot</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo</article-title>
<source/>Genes Dev
          <year>2015</year>
<volume>29</volume>
<issue>16</issue>
<fpage>1707</fpage>
<lpage>1720</lpage>
<pub-id pub-id-type="doi">10.1101/gad.262568.115</pub-id>
<pub-id pub-id-type="pmid">26302789</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Suh</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Surh</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Na</surname>
<given-names>HK</given-names>
</name>
</person-group>
<article-title>Regulation of the tumor suppressor PTEN by natural anticancer compounds</article-title>
<source/>Ann N Y Acad Sci
          <year>2017</year>
<volume>1401</volume>
<issue>1</issue>
<fpage>136</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="doi">10.1111/nyas.13422</pub-id>
<pub-id pub-id-type="pmid">28891094</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uversky</surname>
<given-names>VN</given-names>
</name>
<name>
<surname>Dave</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Iakoucheva</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Malaney</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Metallo</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Pathak</surname>
<given-names>RR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases</article-title>
<source/>Chem Rev
          <year>2014</year>
<volume>114</volume>
<issue>13</issue>
<fpage>6844</fpage>
<lpage>6879</lpage>
<pub-id pub-id-type="doi">10.1021/cr400713r</pub-id>
<pub-id pub-id-type="pmid">24830552</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>JO</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Georgescu</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Di Cristofano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Maehama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association</article-title>
<source/>Cell
          <year>1999</year>
<volume>99</volume>
<issue>3</issue>
<fpage>323</fpage>
<lpage>334</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)81663-3</pub-id>
<pub-id pub-id-type="pmid">10555148</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salmena</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Carracedo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pandolfi</surname>
<given-names>PP</given-names>
</name>
</person-group>
<article-title>Tenets of PTEN tumor suppression</article-title>
<source/>Cell
          <year>2008</year>
<volume>133</volume>
<issue>3</issue>
<fpage>403</fpage>
<lpage>414</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2008.04.013</pub-id>
<pub-id pub-id-type="pmid">18455982</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shnitsar</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bashkurov</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Masson</surname>
<given-names>GR</given-names>
</name>
<name>
<surname>Ogunjimi</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Mosessian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Cabeza</surname>
<given-names>EA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PTEN regulates cilia through Dishevelled</article-title>
<source/>Nat Commun
          <year>2015</year>
<volume>6</volume>
<fpage>8388</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms9388</pub-id>
<pub-id pub-id-type="pmid">26399523</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adey</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ormonde</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Baumgard</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Pero</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Byreddy</surname>
<given-names>DV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding</article-title>
<source/>Cancer Res
          <year>2000</year>
<volume>60</volume>
<issue>1</issue>
<fpage>35</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="pmid">10646847</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meiling-Wesse</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Epple</surname>
<given-names>UD</given-names>
</name>
<name>
<surname>Krick</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Barth</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Appelles</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Voss</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Trs85 (Gsg1), a component of the TRAPP complexes, is required for the organization of the preautophagosomal structure during selective autophagy via the Cvt pathway</article-title>
<source/>J Biol Chem
          <year>2005</year>
<volume>280</volume>
<issue>39</issue>
<fpage>33669</fpage>
<lpage>33678</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M501701200</pub-id>
<pub-id pub-id-type="pmid">16079147</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valiente</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Andrés-Pons</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gomar</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gil</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tapparel</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases</article-title>
<source/>J Biol Chem
          <year>2005</year>
<volume>280</volume>
<issue>32</issue>
<fpage>28936</fpage>
<lpage>28943</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M504761200</pub-id>
<pub-id pub-id-type="pmid">15951562</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cherniack</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Bowlby</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Integrated molecular characterization of uterine Carcinosarcoma</article-title>
<source/>Cancer Cell
          <year>2017</year>
<volume>31</volume>
<issue>3</issue>
<fpage>411</fpage>
<lpage>423</lpage>
<pub-id pub-id-type="doi">10.1016/j.ccell.2017.02.010</pub-id>
<pub-id pub-id-type="pmid">28292439</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gemmill</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Nasarre</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Nair-Menon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cappuzzo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Landi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>D'Incecco</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The neuropilin 2 isoform NRP2b uniquely supports TGF beta-mediated progression in lung cancer</article-title>
<source/>Science Signaling
          <year>2017</year>
<volume>10</volume>
<issue>462</issue>
<fpage>eaag0528</fpage>
<pub-id pub-id-type="doi">10.1126/scisignal.aag0528</pub-id>
<pub-id pub-id-type="pmid">28096505</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Resveratrol reverses doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer</article-title>
<source/>J Exp Clin Cancer Res
          <year>2017</year>
<volume>36</volume>
<issue>1</issue>
<fpage>19</fpage>
<pub-id pub-id-type="doi">10.1186/s13046-016-0487-8</pub-id>
<pub-id pub-id-type="pmid">28126034</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavazzoni</surname>
<given-names>A</given-names>
</name>
<name>
<surname>La Monica</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Alfieri</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ravelli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Van Der Steen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sciarrillo</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN</article-title>
<source/>Oncotarget
          <year>2017</year>
<volume>8</volume>
<issue>32</issue>
<fpage>53068</fpage>
<lpage>53083</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.18087</pub-id>
<pub-id pub-id-type="pmid">28881794</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fritsch</surname>
<given-names>R</given-names>
</name>
<name>
<surname>de Krijger</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Fritsch</surname>
<given-names>K</given-names>
</name>
<name>
<surname>George</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Reason</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>MS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>RAS and RHO families of GTPases directly regulate distinct phosphoinositide 3-kinase isoforms</article-title>
<source/>Cell
          <year>2013</year>
<volume>153</volume>
<issue>5</issue>
<fpage>1050</fpage>
<lpage>1063</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.04.031</pub-id>
<pub-id pub-id-type="pmid">23706742</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCubrey</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>LV</given-names>
</name>
<name>
<surname>Lertpiriyapong</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Steelman</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Abrams</surname>
<given-names>SL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells</article-title>
<source/>Oncotarget
          <year>2017</year>
<volume>8</volume>
<issue>8</issue>
<fpage>14221</fpage>
<lpage>14250</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.13991</pub-id>
<pub-id pub-id-type="pmid">27999207</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwartz</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wongvipat</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Trigwell</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Hancox</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Carver</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Rodrik-Outmezguine</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Feedback suppression of PI3Kalpha signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3Kbeta</article-title>
<source/>Cancer Cell
          <year>2015</year>
<volume>27</volume>
<issue>1</issue>
<fpage>109</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="doi">10.1016/j.ccell.2014.11.008</pub-id>
<pub-id pub-id-type="pmid">25544636</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>TB</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Karam</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Creighton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Joon</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sarcomatoid renal cell carcinoma has a distinct molecular pathogenesis, driver mutation profile, and transcriptional landscape</article-title>
<source/>Clinical Cancer Res
          <year>2017</year>
<volume>23</volume>
<issue>21</issue>
<fpage>6686</fpage>
<lpage>6696</lpage>
<pub-id pub-id-type="doi">10.1158/1078-0432.CCR-17-1057</pub-id>
<pub-id pub-id-type="pmid">28710314</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Millis</surname>
<given-names>SZ</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gatalica</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Kurzrock</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Landscape of Phosphatidylinositol-3-kinase pathway alterations across 19784 diverse solid tumors</article-title>
<source/>JAMA Oncol
          <year>2016</year>
<volume>2</volume>
<issue>12</issue>
<fpage>1565</fpage>
<lpage>1573</lpage>
<pub-id pub-id-type="doi">10.1001/jamaoncol.2016.0891</pub-id>
<pub-id pub-id-type="pmid">27388585</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiregional sequencing reveals genomic alterations and clonal dynamics in primary malignant melanoma of the esophagus</article-title>
<source/>Cancer Res
          <year>2017</year>
<volume>78</volume>
<fpage>338</fpage>
<lpage>347</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-0938</pub-id>
<pub-id pub-id-type="pmid">28972077</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunderson</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Stepper</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gomm</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Hoa</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Morgan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>MD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors</article-title>
<source/>Nat Commun
          <year>2017</year>
<volume>8</volume>
<issue>1</issue>
<fpage>1450</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-017-01078-2</pub-id>
<pub-id pub-id-type="pmid">29133799</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Weiler</surname>
<given-names>SME</given-names>
</name>
<name>
<surname>Rupp</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Toth</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sticht</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cytoplasmic localization of the cell polarity factor Scribble supports liver tumor formation and tumor cell invasiveness</article-title>
<source/>Hepatology (Baltimore, Md)
          <year>2017</year>
<volume>67</volume>
<fpage>1842</fpage>
<lpage>1856</lpage>
<pub-id pub-id-type="doi">10.1002/hep.29669</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alimonti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Carracedo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Clohessy</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Trotman</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Nardella</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Egia</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subtle variations in Pten dose determine cancer susceptibility</article-title>
<source/>Nat Genet
          <year>2010</year>
<volume>42</volume>
<issue>5</issue>
<fpage>454</fpage>
<lpage>458</lpage>
<pub-id pub-id-type="doi">10.1038/ng.556</pub-id>
<pub-id pub-id-type="pmid">20400965</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen-Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Koujak</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Szablocs</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Parsons</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Reduction of Pten dose leads to neoplastic development in multiple organs of Pten (shRNA) mice</article-title>
<source/>Cancer Biol Ther
          <year>2010</year>
<volume>10</volume>
<issue>11</issue>
<fpage>1194</fpage>
<lpage>1200</lpage>
<pub-id pub-id-type="doi">10.4161/cbt.10.11.13814</pub-id>
<pub-id pub-id-type="pmid">20980828</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butler</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Dasouki</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>XP</given-names>
</name>
<name>
<surname>Talebizadeh</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>TN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations</article-title>
<source/>J Med Genet
          <year>2005</year>
<volume>42</volume>
<issue>4</issue>
<fpage>318</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2004.024646</pub-id>
<pub-id pub-id-type="pmid">15805158</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pal</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Barber</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Van de Bunt</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rudge</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Lachlan</surname>
<given-names>KL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PTEN mutations as a cause of constitutive insulin sensitivity and obesity</article-title>
<source/>N Engl J Med
          <year>2012</year>
<volume>367</volume>
<issue>11</issue>
<fpage>1002</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1113966</pub-id>
<pub-id pub-id-type="pmid">22970944</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia-Junco-Clemente</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Golshani</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>PTEN: a master regulator of neuronal structure, function, and plasticity</article-title>
<source/>Commun Integrative Biol
          <year>2014</year>
<volume>7</volume>
<issue>1</issue>
<fpage>e28358</fpage>
<pub-id pub-id-type="doi">10.4161/cib.28358</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwak</surname>
<given-names>YG</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>HK</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>KS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma</article-title>
<source/>J Clin Invest
          <year>2003</year>
<volume>111</volume>
<issue>7</issue>
<fpage>1083</fpage>
<lpage>1092</lpage>
<pub-id pub-id-type="doi">10.1172/JCI16440</pub-id>
<pub-id pub-id-type="pmid">12671058</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuo</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>PR</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>JC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PTEN overexpression attenuates angiogenic processes of endothelial cells by blockade of endothelin-1/endothelin B receptor signaling</article-title>
<source/>Atherosclerosis
          <year>2012</year>
<volume>221</volume>
<issue>2</issue>
<fpage>341</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2010.08.067</pub-id>
<pub-id pub-id-type="pmid">22341591</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Domanskyi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Geissler</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vinnikov</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Alter</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Schober</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vogt</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models</article-title>
<source/>FASEB J
          <year>2011</year>
<volume>25</volume>
<issue>9</issue>
<fpage>2898</fpage>
<lpage>2910</lpage>
<pub-id pub-id-type="doi">10.1096/fj.11-181958</pub-id>
<pub-id pub-id-type="pmid">21593433</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Preservation of GABAA receptor function by PTEN inhibition protects against neuronal death in ischemic stroke</article-title>
<source/>Stroke
          <year>2010</year>
<volume>41</volume>
<issue>5</issue>
<fpage>1018</fpage>
<lpage>1026</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.110.579011</pub-id>
<pub-id pub-id-type="pmid">20360540</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knafo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sanchez-Puelles</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Palomer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Delgado</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Draffin</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Mingo</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PTEN recruitment controls synaptic and cognitive function in Alzheimer's models</article-title>
<source/>Nat Neurosci
          <year>2016</year>
<volume>19</volume>
<issue>3</issue>
<fpage>443</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="doi">10.1038/nn.4225</pub-id>
<pub-id pub-id-type="pmid">26780512</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stambolic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>MacPherson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sas</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Snow</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Regulation of PTEN transcription by p53</article-title>
<source/>Mol Cell
          <year>2001</year>
<volume>8</volume>
<issue>2</issue>
<fpage>317</fpage>
<lpage>325</lpage>
<pub-id pub-id-type="doi">10.1016/S1097-2765(01)00323-9</pub-id>
<pub-id pub-id-type="pmid">11545734</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torres</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pulido</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation</article-title>
<source/>J Biol Chem
          <year>2001</year>
<volume>276</volume>
<issue>2</issue>
<fpage>993</fpage>
<lpage>998</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M009134200</pub-id>
<pub-id pub-id-type="pmid">11035045</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Folino</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Accomasso</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Giachino</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Montarolo</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Losano</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pagliaro</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Apelin-induced cardioprotection against ischaemia/reperfusion injury: roles of epidermal growth factor and Src</article-title>
<source/>Acta Physiol
          <year>2018</year>
<volume>222</volume>
<fpage>e13005</fpage>
<pub-id pub-id-type="doi">10.1111/apha.12924</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taft</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Pheasant</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mattick</surname>
<given-names>JS</given-names>
</name>
</person-group>
<article-title>The relationship between non-protein-coding DNA and eukaryotic complexity</article-title>
<source/>BioEssays
          <year>2007</year>
<volume>29</volume>
<issue>3</issue>
<fpage>288</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="doi">10.1002/bies.20544</pub-id>
<pub-id pub-id-type="pmid">17295292</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esteller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pandolfi</surname>
<given-names>PP</given-names>
</name>
</person-group>
<article-title>The Epitranscriptome of noncoding RNAs in Cancer</article-title>
<source/>Cancer Discovery
          <year>2017</year>
<volume>7</volume>
<issue>4</issue>
<fpage>359</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="doi">10.1158/2159-8290.CD-16-1292</pub-id>
<pub-id pub-id-type="pmid">28320778</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Telonis</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Magee</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Loher</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chervoneva</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Londin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rigoutsos</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Knowledge about the presence or absence of miRNA isoforms (isomiRs) can successfully discriminate amongst 32 TCGA cancer types</article-title>
<source/>Nucleic Acids Res
          <year>2017</year>
<volume>45</volume>
<issue>6</issue>
<fpage>2973</fpage>
<lpage>2985</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkx082</pub-id>
<pub-id pub-id-type="pmid">28206648</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahadi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sablok</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hutvagner</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>miRTar2GO: a novel rule-based model learning method for cell line specific microRNA target prediction that integrates Ago2 CLIP-Seq and validated microRNA-target interaction data</article-title>
<source/>Nucleic Acids Res
          <year>2017</year>
<volume>45</volume>
<issue>6</issue>
<fpage>e42</fpage>
<pub-id pub-id-type="doi">10.1093/nar/gkw1185</pub-id>
<pub-id pub-id-type="pmid">27903911</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dooley</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lagou</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Garcia-Perez</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Himmelreich</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Liston</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>miR-29a-deficiency does not modify the course of murine pancreatic acinar carcinoma</article-title>
<source/>Oncotarget
          <year>2017</year>
<volume>8</volume>
<issue>16</issue>
<fpage>26911</fpage>
<lpage>26917</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.15850</pub-id>
<pub-id pub-id-type="pmid">28460473</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engreitz</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Sirokman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>McDonel</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Shishkin</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Surka</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent pre-mRNAs and chromatin sites</article-title>
<source/>Cell
          <year>2014</year>
<volume>159</volume>
<issue>1</issue>
<fpage>188</fpage>
<lpage>199</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2014.08.018</pub-id>
<pub-id pub-id-type="pmid">25259926</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Runtsch</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>O'Neill</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>GOTcha: lncRNA-ACOD1 targets metabolism during viral infection</article-title>
<source/>Cell Res
          <year>2018</year>
<volume>28</volume>
<fpage>137</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="doi">10.1038/cr.2017.153</pub-id>
<pub-id pub-id-type="pmid">29192676</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michelini</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pitchiaya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vitelli</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gioia</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Pessina</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Damage-induced lncRNAs control the DNA damage response through interaction with DDRNAs at individual double-strand breaks</article-title>
<source/>Nat Cell Biol
          <year>2017</year>
<volume>19</volume>
<issue>12</issue>
<fpage>1400</fpage>
<lpage>1411</lpage>
<pub-id pub-id-type="doi">10.1038/ncb3643</pub-id>
<pub-id pub-id-type="pmid">29180822</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Calvopina</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Donahue</surname>
<given-names>TR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PTEN loss accelerates KrasG12D-induced pancreatic cancer development</article-title>
<source/>Cancer Res
          <year>2010</year>
<volume>70</volume>
<issue>18</issue>
<fpage>7114</fpage>
<lpage>7124</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-10-1649</pub-id>
<pub-id pub-id-type="pmid">20807812</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ge</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nikolova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Reva</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Strand-specific in vivo screen of cancer-associated miRNAs unveils a role for miR-21( *) in SCC progression</article-title>
<source/>Nat Cell Biol
          <year>2016</year>
<volume>18</volume>
<issue>1</issue>
<fpage>111</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1038/ncb3275</pub-id>
<pub-id pub-id-type="pmid">26619149</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Conklin</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The oncogenic microRNA miR-21 promotes regulated necrosis in mice</article-title>
<source/>Nat Commun
          <year>2015</year>
<volume>6</volume>
<fpage>7151</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms8151</pub-id>
<pub-id pub-id-type="pmid">25990308</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhagat</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Sokol</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kessel</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Caceres</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gundabolu</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>miR-21 mediates hematopoietic suppression in MDS by activating TGF-beta signaling</article-title>
<source/>Blood
          <year>2013</year>
<volume>121</volume>
<issue>15</issue>
<fpage>2875</fpage>
<lpage>2881</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2011-12-397067</pub-id>
<pub-id pub-id-type="pmid">23390194</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>RY</given-names>
</name>
<name>
<surname>Horvat</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Pinkerton</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Starkey</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Essilfie</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Mayall</surname>
<given-names>JR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2</article-title>
<source/>J Allergy Clin Immunol
          <year>2017</year>
<volume>139</volume>
<issue>2</issue>
<fpage>519</fpage>
<lpage>532</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2016.04.038</pub-id>
<pub-id pub-id-type="pmid">27448447</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caviglia</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Gwak</surname>
<given-names>GY</given-names>
</name>
<name>
<surname>Affo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNA-21 and Dicer are Dispensable for Hepatic Stellate Cell Activation and the Development of Liver Fibrosis</article-title>
<source/>Hepatology (Baltimore, Md)
          <year>2018</year>
<volume>67</volume>
<fpage>2414</fpage>
<lpage>2429</lpage>
<pub-id pub-id-type="doi">10.1002/hep.29627</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bei</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>miR-17-3p contributes to exercise-induced cardiac growth and protects against myocardial ischemia-reperfusion injury</article-title>
<source/>Theranostics
          <year>2017</year>
<volume>7</volume>
<issue>3</issue>
<fpage>664</fpage>
<lpage>676</lpage>
<pub-id pub-id-type="doi">10.7150/thno.15162</pub-id>
<pub-id pub-id-type="pmid">28255358</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells</article-title>
<source/>J Exp Clin Cancer Res
          <year>2017</year>
<volume>36</volume>
<issue>1</issue>
<fpage>53</fpage>
<pub-id pub-id-type="doi">10.1186/s13046-017-0528-y</pub-id>
<pub-id pub-id-type="pmid">28407783</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Targeting miR-21 with Sophocarpine inhibits tumor progression and reverses epithelial-mesenchymal transition in head and neck Cancer</article-title>
<source/>Mol Ther
          <year>2017</year>
<volume>25</volume>
<issue>9</issue>
<fpage>2129</fpage>
<lpage>2139</lpage>
<pub-id pub-id-type="doi">10.1016/j.ymthe.2017.05.008</pub-id>
<pub-id pub-id-type="pmid">28571917</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gumireddy</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression</article-title>
<source/>Mol Cancer Ther
          <year>2014</year>
<volume>13</volume>
<issue>12</issue>
<fpage>3086</fpage>
<lpage>3097</lpage>
<pub-id pub-id-type="doi">10.1158/1535-7163.MCT-14-0245</pub-id>
<pub-id pub-id-type="pmid">25249556</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egawa</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jingushi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hirono</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ueda</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kitae</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nakata</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>20574</fpage>
<pub-id pub-id-type="doi">10.1038/srep20574</pub-id>
<pub-id pub-id-type="pmid">26837847</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bahr</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zanesi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>miR-130a deregulates PTEN and stimulates tumor growth</article-title>
<source/>Cancer Res
          <year>2017</year>
<volume>77</volume>
<issue>22</issue>
<fpage>6168</fpage>
<lpage>6178</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-0530</pub-id>
<pub-id pub-id-type="pmid">28935812</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>YF</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>JC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNA-130a alleviates human coronary artery endothelial cell injury and inflammatory responses by targeting PTEN via activating PI3K/Akt/eNOS signaling pathway</article-title>
<source/>Oncotarget
          <year>2016</year>
<volume>7</volume>
<issue>44</issue>
<fpage>71922</fpage>
<lpage>71936</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.12431</pub-id>
<pub-id pub-id-type="pmid">27713121</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Toledo</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Gyllborg</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Salto</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Carlos Villaescusa</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Niche-derived laminin-511 promotes midbrain dopaminergic neuron survival and differentiation through YAP</article-title>
<source/>Sci Signal
          <year>2017</year>
<volume>10</volume>
<issue>493</issue>
<fpage>eaal4165</fpage>
<pub-id pub-id-type="doi">10.1126/scisignal.aal4165</pub-id>
<pub-id pub-id-type="pmid">28831020</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>MiR-130 exerts tumor suppressive function on the tumorigenesis of human non-small cell lung cancer by targeting PTEN</article-title>
<source/>Am J Transl Res
          <year>2017</year>
<volume>9</volume>
<issue>4</issue>
<fpage>1856</fpage>
<lpage>1865</lpage>
<pub-id pub-id-type="pmid">28469790</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Upregulation of microrna-451 increases the sensitivity of A549 cells to radiotherapy through enhancement of apoptosis</article-title>
<source/>Thoracic Cancer
          <year>2016</year>
<volume>7</volume>
<issue>2</issue>
<fpage>226</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1111/1759-7714.12318</pub-id>
<pub-id pub-id-type="pmid">27042226</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bandyopadhyay</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Alosh</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hayek</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Daaboul</surname>
<given-names>MF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comparative analysis of differentially expressed miRNAs and their downstream mRNAs in ovarian Cancer and its associated endometriosis</article-title>
<source/>J Cancer Sci Ther
          <year>2015</year>
<volume>7</volume>
<issue>7</issue>
<fpage>258</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="pmid">26819681</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garofalo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Di Leva</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nuovo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Suh</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Ngankeu</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>miR-221&amp;222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation</article-title>
<source/>Cancer Cell
          <year>2009</year>
<volume>16</volume>
<issue>6</issue>
<fpage>498</fpage>
<lpage>509</lpage>
<pub-id pub-id-type="doi">10.1016/j.ccr.2009.10.014</pub-id>
<pub-id pub-id-type="pmid">19962668</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhuang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>ZF</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Glycine confers neuroprotection through microRNA-301a/PTEN signaling</article-title>
<source/>Mol Brain
          <year>2016</year>
<volume>9</volume>
<issue>1</issue>
<fpage>59</fpage>
<pub-id pub-id-type="doi">10.1186/s13041-016-0241-3</pub-id>
<pub-id pub-id-type="pmid">27230112</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sui</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MiR-301a mediates the effect of IL-6 on the AKT/GSK pathway and hepatic glycogenesis by regulating PTEN expression</article-title>
<source/>Cellular Physiol Biochem
          <year>2015</year>
<volume>35</volume>
<issue>4</issue>
<fpage>1413</fpage>
<lpage>1424</lpage>
<pub-id pub-id-type="doi">10.1159/000373962</pub-id>
<pub-id pub-id-type="pmid">25790935</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/beta-catenin signaling</article-title>
<source/>Gene
          <year>2014</year>
<volume>535</volume>
<issue>2</issue>
<fpage>191</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="doi">10.1016/j.gene.2013.11.035</pub-id>
<pub-id pub-id-type="pmid">24315818</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Itonaga</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Iwasaki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tsumura</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells</article-title>
<source/>Int J Oncol
          <year>2016</year>
<volume>48</volume>
<issue>4</issue>
<fpage>1531</fpage>
<lpage>1540</lpage>
<pub-id pub-id-type="doi">10.3892/ijo.2016.3379</pub-id>
<pub-id pub-id-type="pmid">26846737</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expression of MicroRNA-301a and its functional roles in malignant melanoma</article-title>
<source/>Cellular Physiol Biochem
          <year>2016</year>
<volume>40</volume>
<issue>1–2</issue>
<fpage>230</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1159/000452540</pub-id>
<pub-id pub-id-type="pmid">27855389</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth</article-title>
<source/>Cell Res
          <year>2014</year>
<volume>24</volume>
<issue>10</issue>
<fpage>1164</fpage>
<lpage>1180</lpage>
<pub-id pub-id-type="doi">10.1038/cr.2014.121</pub-id>
<pub-id pub-id-type="pmid">25223704</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>W</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>O'Donnell</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN</article-title>
<source/>Cancer Res
          <year>2008</year>
<volume>68</volume>
<issue>2</issue>
<fpage>425</fpage>
<lpage>433</lpage>
<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-2488</pub-id>
<pub-id pub-id-type="pmid">18199536</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jindra</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Bagley</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Godwin</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Iacomini</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten</article-title>
<source/>Journal of immunology (Baltimore, Md : 1950)
          <year>2010</year>
<volume>185</volume>
<issue>2</issue>
<fpage>990</fpage>
<lpage>997</lpage>
<pub-id pub-id-type="doi">10.4049/jimmunol.1000793</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lv</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bian</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>MicroRNA-214 protects cardiac myocytes against H2O2-induced injury</article-title>
<source/>J Cell Biochem
          <year>2014</year>
<volume>115</volume>
<issue>1</issue>
<fpage>93</fpage>
<lpage>101</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.24636</pub-id>
<pub-id pub-id-type="pmid">23904244</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tumor-suppressor NFkappaB2 p100 interacts with ERK2 and stabilizes PTEN mRNA via inhibition of miR-494</article-title>
<source/>Oncogene
          <year>2016</year>
<volume>35</volume>
<issue>31</issue>
<fpage>4080</fpage>
<lpage>4090</lpage>
<pub-id pub-id-type="doi">10.1038/onc.2015.470</pub-id>
<pub-id pub-id-type="pmid">26686085</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>XP</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury</article-title>
<source/>Circulation
          <year>2010</year>
<volume>122</volume>
<issue>13</issue>
<fpage>1308</fpage>
<lpage>1318</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.964684</pub-id>
<pub-id pub-id-type="pmid">20837890</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway</article-title>
<source/>Cancer Sci
          <year>2017</year>
<volume>108</volume>
<fpage>620</fpage>
<lpage>631</lpage>
<pub-id pub-id-type="doi">10.1111/cas.13177</pub-id>
<pub-id pub-id-type="pmid">28132399</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway</article-title>
<source/>Sci Rep
          <year>2017</year>
<volume>7</volume>
<fpage>41942</fpage>
<pub-id pub-id-type="doi">10.1038/srep41942</pub-id>
<pub-id pub-id-type="pmid">28165066</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNA-616 promotes the migration, invasion and epithelial-mesenchymal transition of HCC by targeting PTEN</article-title>
<source/>Oncol Rep
          <year>2016</year>
<volume>35</volume>
<issue>1</issue>
<fpage>366</fpage>
<lpage>374</lpage>
<pub-id pub-id-type="doi">10.3892/or.2015.4334</pub-id>
<pub-id pub-id-type="pmid">26499912</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>XL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNA-19 triggers epithelial-mesenchymal transition of lung cancer cells accompanied by growth inhibition</article-title>
<source/>Lab Invest J Tech Methods Pathol
          <year>2015</year>
<volume>95</volume>
<issue>9</issue>
<fpage>1056</fpage>
<lpage>1070</lpage>
<pub-id pub-id-type="doi">10.1038/labinvest.2015.76</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ke</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>YW</given-names>
</name>
</person-group>
<article-title>MiR-92a promotes cell metastasis of colorectal Cancer through PTEN-mediated PI3K/AKT pathway</article-title>
<source/>Ann Surg Oncol
          <year>2015</year>
<volume>22</volume>
<issue>8</issue>
<fpage>2649</fpage>
<lpage>2655</lpage>
<pub-id pub-id-type="doi">10.1245/s10434-014-4305-2</pub-id>
<pub-id pub-id-type="pmid">25515201</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN</article-title>
<source/>Oncotarget
          <year>2015</year>
<volume>6</volume>
<issue>30</issue>
<fpage>30239</fpage>
<lpage>30250</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.4972</pub-id>
<pub-id pub-id-type="pmid">26317552</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA</article-title>
<source/>Oncogene
          <year>2015</year>
<volume>34</volume>
<issue>14</issue>
<fpage>1768</fpage>
<lpage>1779</lpage>
<pub-id pub-id-type="doi">10.1038/onc.2014.131</pub-id>
<pub-id pub-id-type="pmid">24837367</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sui</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transition</article-title>
<source/>Cancer Lett
          <year>2015</year>
<volume>364</volume>
<issue>1</issue>
<fpage>33</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1016/j.canlet.2015.04.023</pub-id>
<pub-id pub-id-type="pmid">25931210</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeitels</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Acharya</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chivukula</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chivukula</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Anandam</surname>
<given-names>JL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tumor suppression by miR-26 overrides potential oncogenic activity in intestinal tumorigenesis</article-title>
<source/>Genes Dev
          <year>2014</year>
<volume>28</volume>
<issue>23</issue>
<fpage>2585</fpage>
<lpage>2590</lpage>
<pub-id pub-id-type="doi">10.1101/gad.250951.114</pub-id>
<pub-id pub-id-type="pmid">25395662</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mavrakis</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Van Der Meulen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wolfe</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Mets</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Taghon</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL)</article-title>
<source/>Nat Genet
          <year>2011</year>
<volume>43</volume>
<issue>7</issue>
<fpage>673</fpage>
<lpage>678</lpage>
<pub-id pub-id-type="doi">10.1038/ng.858</pub-id>
<pub-id pub-id-type="pmid">21642990</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Shiang</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors</article-title>
<source/>Blood
          <year>2015</year>
<volume>125</volume>
<issue>8</issue>
<fpage>1302</fpage>
<lpage>1313</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2014-06-581926</pub-id>
<pub-id pub-id-type="pmid">25515961</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Longacre</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Housman</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Leary</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lapinska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Heerboth</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A comparative analysis of genetic and epigenetic events of breast and ovarian Cancer related to tumorigenesis</article-title>
<source/>Int J Mol Sci
          <year>2016</year>
<volume>17</volume>
<issue>5</issue>
<fpage>E759</fpage>
<pub-id pub-id-type="doi">10.3390/ijms17050759</pub-id>
<pub-id pub-id-type="pmid">27213343</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tagde</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rajabi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Stroopinsky</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gali</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bouillez</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia</article-title>
<source/>Oncotarget
          <year>2016</year>
<volume>7</volume>
<issue>26</issue>
<fpage>38974</fpage>
<lpage>38987</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.9777</pub-id>
<pub-id pub-id-type="pmid">27259275</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>YL</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Tiao</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>YH</given-names>
</name>
</person-group>
<article-title>MicroRNA-29a alleviates bile duct ligation exacerbation of hepatic fibrosis in mice through epigenetic control of methyltransferases</article-title>
<source/>Int J Mol Sci
          <year>2017</year>
<volume>18</volume>
<issue>1</issue>
<fpage>E192</fpage>
<pub-id pub-id-type="doi">10.3390/ijms18010192</pub-id>
<pub-id pub-id-type="pmid">28106784</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation--a novel mechanism suppressing liver fibrosis</article-title>
<source/>FEBS J
          <year>2014</year>
<volume>281</volume>
<issue>1</issue>
<fpage>88</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1111/febs.12574</pub-id>
<pub-id pub-id-type="pmid">24138392</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H</given-names>
</name>
<name>
<surname>He</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A</article-title>
<source/>Oncol Lett
          <year>2017</year>
<volume>13</volume>
<issue>1</issue>
<fpage>329</fpage>
<lpage>338</lpage>
<pub-id pub-id-type="doi">10.3892/ol.2016.5423</pub-id>
<pub-id pub-id-type="pmid">28123563</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Molina</surname>
<given-names>JR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Restoration of miR-101 suppresses lung tumorigenesis through inhibition of DNMT3a-dependent DNA methylation</article-title>
<source/>Cell Death Dis
          <year>2014</year>
<volume>5</volume>
<fpage>e1413</fpage>
<pub-id pub-id-type="doi">10.1038/cddis.2014.380</pub-id>
<pub-id pub-id-type="pmid">25210796</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qadir</surname>
<given-names>XV</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway</article-title>
<source/>Am J Pathol
          <year>2014</year>
<volume>184</volume>
<issue>8</issue>
<fpage>2355</fpage>
<lpage>2364</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajpath.2014.05.004</pub-id>
<pub-id pub-id-type="pmid">24911372</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cesana</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cacchiarelli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Legnini</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Santini</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sthandier</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Chinappi</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA</article-title>
<source/>Cell
          <year>2011</year>
<volume>147</volume>
<issue>2</issue>
<fpage>358</fpage>
<lpage>369</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2011.09.028</pub-id>
<pub-id pub-id-type="pmid">22000014</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karreth</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Tay</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Perna</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ala</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Rust</surname>
<given-names>AG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma</article-title>
<source/>Cell
          <year>2011</year>
<volume>147</volume>
<issue>2</issue>
<fpage>382</fpage>
<lpage>395</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2011.09.032</pub-id>
<pub-id pub-id-type="pmid">22000016</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>LncRNA lnc-RI regulates homologous recombination repair of DNA double-strand breaks by stabilizing RAD51 mRNA as a competitive endogenous RNA</article-title>
<source/>Nucleic Acids Res
          <year>2018</year>
<volume>46</volume>
<fpage>717</fpage>
<lpage>729</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkx1224</pub-id>
<pub-id pub-id-type="pmid">29216366</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tay</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kats</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Salmena</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Ala</surname>
<given-names>U</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs</article-title>
<source/>Cell
          <year>2011</year>
<volume>147</volume>
<issue>2</issue>
<fpage>344</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2011.09.029</pub-id>
<pub-id pub-id-type="pmid">22000013</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PTENp1, a natural sponge of miR-21, mediates PTEN expression to inhibit the proliferation of oral squamous cell carcinoma</article-title>
<source/>Mol Carcinog
          <year>2017</year>
<volume>56</volume>
<issue>4</issue>
<fpage>1322</fpage>
<lpage>1334</lpage>
<pub-id pub-id-type="doi">10.1002/mc.22594</pub-id>
<pub-id pub-id-type="pmid">27862321</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>GY</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>SM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation</article-title>
<source/>Biomaterials
          <year>2015</year>
<volume>44</volume>
<fpage>71</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1016/j.biomaterials.2014.12.023</pub-id>
<pub-id pub-id-type="pmid">25617127</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poliseno</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Salmena</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Carver</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Haveman</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Pandolfi</surname>
<given-names>PP</given-names>
</name>
</person-group>
<article-title>A coding-independent function of gene and pseudogene mRNAs regulates tumour biology</article-title>
<source/>Nature
          <year>2010</year>
<volume>465</volume>
<issue>7301</issue>
<fpage>1033</fpage>
<lpage>1038</lpage>
<pub-id pub-id-type="doi">10.1038/nature09144</pub-id>
<pub-id pub-id-type="pmid">20577206</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer</article-title>
<source/>Oncotarget
          <year>2017</year>
<volume>8</volume>
<issue>16</issue>
<fpage>26079</fpage>
<lpage>26089</lpage>
<pub-id pub-id-type="pmid">28212532</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phelps</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Coss</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Registered report: coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs</article-title>
<source/>elife
          <year>2016</year>
<volume>5</volume>
<fpage>e12470</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.12470</pub-id>
<pub-id pub-id-type="pmid">26943900</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kerwin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Griner</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Registered report: a coding-independent function of gene and pseudogene mRNAs regulates tumour biology</article-title>
<source/>elife
          <year>2015</year>
<volume>4</volume>
<fpage>e13015</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.13015</pub-id>
<pub-id pub-id-type="pmid">26599840</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gupta</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Horlings</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>DJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis</article-title>
<source/>Nature
          <year>2010</year>
<volume>464</volume>
<issue>7291</issue>
<fpage>1071</fpage>
<lpage>1076</lpage>
<pub-id pub-id-type="doi">10.1038/nature08975</pub-id>
<pub-id pub-id-type="pmid">20393566</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sparmann</surname>
<given-names>A</given-names>
</name>
<name>
<surname>van Lohuizen</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Polycomb silencers control cell fate, development and cancer</article-title>
<source/>Nat Rev Cancer
          <year>2006</year>
<volume>6</volume>
<issue>11</issue>
<fpage>846</fpage>
<lpage>856</lpage>
<pub-id pub-id-type="doi">10.1038/nrc1991</pub-id>
<pub-id pub-id-type="pmid">17060944</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rinn</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Kertesz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Squazzo</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Brugmann</surname>
<given-names>SA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs</article-title>
<source/>Cell
          <year>2007</year>
<volume>129</volume>
<issue>7</issue>
<fpage>1311</fpage>
<lpage>1323</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2007.05.022</pub-id>
<pub-id pub-id-type="pmid">17604720</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>He</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>HOTAIR functions as a competing endogenous RNA to regulate PTEN expression by inhibiting miR-19 in cardiac hypertrophy</article-title>
<source/>Mol Cell Biochem
          <year>2017</year>
<volume>432</volume>
<issue>1–2</issue>
<fpage>179</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="doi">10.1007/s11010-017-3008-y</pub-id>
<pub-id pub-id-type="pmid">28316060</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sui</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long non-coding RNA Linc-USP16 functions as a tumour suppressor in hepatocellular carcinoma by regulating PTEN expression</article-title>
<source/>Cell Physiol Biochem
          <year>2017</year>
<volume>44</volume>
<issue>3</issue>
<fpage>1188</fpage>
<lpage>1198</lpage>
<pub-id pub-id-type="doi">10.1159/000485449</pub-id>
<pub-id pub-id-type="pmid">29179215</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ba</surname>
<given-names>Zhiwen</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Lili</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>Songnan</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Xiaofang</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Zhenping</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>Guangchen</given-names>
</name>
</person-group>
<article-title>Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a</article-title>
<source/>Cell Proliferation
          <year>2017</year>
<volume>51</volume>
<issue>1</issue>
<fpage>e12409</fpage>
<pub-id pub-id-type="doi">10.1111/cpr.12409</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>LncRNA CASC2 interacts with miR-181a to modulate glioma growth and resistance to TMZ through PTEN pathway</article-title>
<source/>J Cell Biochem
          <year>2017</year>
<volume>118</volume>
<issue>7</issue>
<fpage>1889</fpage>
<lpage>1899</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.25910</pub-id>
<pub-id pub-id-type="pmid">28121023</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin</article-title>
<source/>Arch Biochem Biophys
          <year>2017</year>
<volume>623–624</volume>
<fpage>20</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1016/j.abb.2017.05.001</pub-id>
<pub-id pub-id-type="pmid">28495512</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>NQ</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>XJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Crosstalk between Meg3 and miR-1297 regulates growth of testicular germ cell tumor through PTEN/PI3K/AKT pathway</article-title>
<source/>Am J Transl Res
          <year>2016</year>
<volume>8</volume>
<issue>2</issue>
<fpage>1091</fpage>
<lpage>1099</lpage>
<pub-id pub-id-type="pmid">27158395</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>MicroRNA-1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling</article-title>
<source/>Oncol Rep
          <year>2017</year>
<volume>38</volume>
<issue>4</issue>
<fpage>2435</fpage>
<lpage>2443</lpage>
<pub-id pub-id-type="doi">10.3892/or.2017.5884</pub-id>
<pub-id pub-id-type="pmid">28791363</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>XL</given-names>
</name>
</person-group>
<article-title>Long noncoding RNA MEG3 suppresses glioma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of miR-19a</article-title>
<source/>Oncol Res
          <year>2017</year>
<volume>25</volume>
<issue>9</issue>
<fpage>1471</fpage>
<lpage>1478</lpage>
<pub-id pub-id-type="doi">10.3727/096504017X14886689179993</pub-id>
<pub-id pub-id-type="pmid">28276316</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long noncoding RNA MEG3 suppressed endothelial cell proliferation and migration through regulating miR-21</article-title>
<source/>Am J Transl Res
          <year>2017</year>
<volume>9</volume>
<issue>7</issue>
<fpage>3326</fpage>
<lpage>3335</lpage>
<pub-id pub-id-type="pmid">28804550</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer</article-title>
<source/>Oncotarget
          <year>2016</year>
<volume>7</volume>
<issue>19</issue>
<fpage>27778</fpage>
<lpage>27786</lpage>
<pub-id pub-id-type="pmid">27034004</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21</article-title>
<source/>Tumour Biol
          <year>2016</year>
<volume>37</volume>
<issue>2</issue>
<fpage>2691</fpage>
<lpage>2702</lpage>
<pub-id pub-id-type="doi">10.1007/s13277-015-4111-x</pub-id>
<pub-id pub-id-type="pmid">26404135</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ou</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis</article-title>
<source/>Biomed Pharmacother
          <year>2017</year>
<volume>93</volume>
<fpage>570</fpage>
<lpage>579</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopha.2017.06.089</pub-id>
<pub-id pub-id-type="pmid">28686971</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>JJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR-21 via PTEN/MMP-2 signaling pathway</article-title>
<source/>Toxicology
          <year>2017</year>
<volume>386</volume>
<fpage>11</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="doi">10.1016/j.tox.2017.05.007</pub-id>
<pub-id pub-id-type="pmid">28526319</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>WQ</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>LncRNA-GAS5 induces PTEN expression through inhibiting miR-103 in endometrial cancer cells</article-title>
<source/>J Biomed Sci
          <year>2015</year>
<volume>22</volume>
<fpage>100</fpage>
<pub-id pub-id-type="doi">10.1186/s12929-015-0213-4</pub-id>
<pub-id pub-id-type="pmid">26511107</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205</article-title>
<source/>Tumour Biol
          <year>2017</year>
<volume>39</volume>
<issue>7</issue>
<fpage>1010428317711315</fpage>
<pub-id pub-id-type="pmid">28671039</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>ZQ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>XS</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long non-coding RNA GAS5 suppresses pancreatic cancer metastasis through modulating miR-32-5p/PTEN axis</article-title>
<source/>Cell Biosci
          <year>2017</year>
<volume>7</volume>
<fpage>66</fpage>
<pub-id pub-id-type="doi">10.1186/s13578-017-0192-0</pub-id>
<pub-id pub-id-type="pmid">29225772</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression</article-title>
<source/>BMC Cancer
          <year>2017</year>
<volume>17</volume>
<issue>1</issue>
<fpage>248</fpage>
<pub-id pub-id-type="doi">10.1186/s12885-017-3216-6</pub-id>
<pub-id pub-id-type="pmid">28388883</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Che</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Long coding RNA XIST contributes to neuronal apoptosis through the downregulation of AKT phosphorylation and is negatively regulated by miR-494 in rat spinal cord injury</article-title>
<source/>Int J Mol Sci
          <year>2017</year>
<volume>18</volume>
<issue>4</issue>
<fpage>E732</fpage>
<pub-id pub-id-type="doi">10.3390/ijms18040732</pub-id>
<pub-id pub-id-type="pmid">28368292</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Long noncoding RNA NBAT1 negatively modulates growth and metastasis of osteosarcoma cells through suppression of miR-21</article-title>
<source/>Am J Cancer Res
          <year>2017</year>
<volume>7</volume>
<issue>10</issue>
<fpage>2009</fpage>
<lpage>2019</lpage>
<pub-id pub-id-type="pmid">29119050</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erho</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Crisan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vergara</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Mitra</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Ghadessi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Buerki</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<issue>6</issue>
<fpage>e66855</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0066855</pub-id>
<pub-id pub-id-type="pmid">23826159</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Schultz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hieronymus</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gopalan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Carver</surname>
<given-names>BS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Integrative genomic profiling of human prostate cancer</article-title>
<source/>Cancer Cell
          <year>2010</year>
<volume>18</volume>
<issue>1</issue>
<fpage>11</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1016/j.ccr.2010.05.026</pub-id>
<pub-id pub-id-type="pmid">20579941</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hacisuleyman</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fei</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer</article-title>
<source/>Nat Commun
          <year>2016</year>
<volume>7</volume>
<fpage>10982</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms10982</pub-id>
<pub-id pub-id-type="pmid">26975529</pub-id>
</element-citation>
</ref>
<ref id="CR127">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>An</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>Long non-coding RNA TUG1 acts as a miR-26a sponge in human glioma cells</article-title>
<source/>Biochem Biophys Res Commun
          <year>2016</year>
<volume>477</volume>
<issue>4</issue>
<fpage>743</fpage>
<lpage>748</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2016.06.129</pub-id>
<pub-id pub-id-type="pmid">27363339</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Xi</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long noncoding RNA associated-competing endogenous RNAs in gastric cancer</article-title>
<source/>Sci Rep
          <year>2014</year>
<volume>4</volume>
<fpage>6088</fpage>
<pub-id pub-id-type="doi">10.1038/srep06088</pub-id>
<pub-id pub-id-type="pmid">25124853</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>LncRNA FER1L4 suppresses cancer cell proliferation and cycle by regulating PTEN expression in endometrial carcinoma</article-title>
<source/>Biochem Biophys Res Commun
          <year>2016</year>
<volume>478</volume>
<issue>2</issue>
<fpage>507</fpage>
<lpage>512</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2016.06.160</pub-id>
<pub-id pub-id-type="pmid">27381864</pub-id>
</element-citation>
</ref>
<ref id="CR130">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yue</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer</article-title>
<source/>Cancer Sci
          <year>2015</year>
<volume>106</volume>
<issue>10</issue>
<fpage>1323</fpage>
<lpage>1332</lpage>
<pub-id pub-id-type="doi">10.1111/cas.12759</pub-id>
<pub-id pub-id-type="pmid">26224446</pub-id>
</element-citation>
</ref>
<ref id="CR131">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression</article-title>
<source/>Sci Rep
          <year>2015</year>
<volume>5</volume>
<fpage>13445</fpage>
<pub-id pub-id-type="doi">10.1038/srep13445</pub-id>
<pub-id pub-id-type="pmid">26306906</pub-id>
</element-citation>
</ref>
<ref id="CR132">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Identification of a novel lincRNA-p21-miR-181b-PTEN signaling Cascade in liver fibrosis</article-title>
<source/>Mediat Inflamm
          <year>2016</year>
<volume>2016</volume>
<fpage>9856538</fpage>
<pub-id pub-id-type="doi">10.1155/2016/9856538</pub-id>
</element-citation>
</ref>
<ref id="CR133">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnsson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ackley</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vidarsdottir</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lui</surname>
<given-names>WO</given-names>
</name>
<name>
<surname>Corcoran</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Grander</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells</article-title>
<source/>Nat Struct Mol Biol
          <year>2013</year>
<volume>20</volume>
<issue>4</issue>
<fpage>440</fpage>
<lpage>446</lpage>
<pub-id pub-id-type="doi">10.1038/nsmb.2516</pub-id>
<pub-id pub-id-type="pmid">23435381</pub-id>
</element-citation>
</ref>
<ref id="CR134">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>HOTAIR epigenetically modulates PTEN expression via MicroRNA-29b: a novel mechanism in regulation of liver fibrosis</article-title>
<source/>Mol Ther
          <year>2017</year>
<volume>25</volume>
<issue>1</issue>
<fpage>205</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="doi">10.1016/j.ymthe.2016.10.015</pub-id>
<pub-id pub-id-type="pmid">28129115</pub-id>
</element-citation>
</ref>
<ref id="CR135">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma</article-title>
<source/>Am J Pathol
          <year>2013</year>
<volume>182</volume>
<issue>1</issue>
<fpage>64</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajpath.2012.08.042</pub-id>
<pub-id pub-id-type="pmid">23141928</pub-id>
</element-citation>
</ref>
<ref id="CR136">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lister</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Shevchenko</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Walshe</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Groen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Johnsson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Vidarsdottir</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The molecular dynamics of long noncoding RNA control of transcription in PTEN and its pseudogene</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2017</year>
<volume>114</volume>
<issue>37</issue>
<fpage>9942</fpage>
<lpage>9947</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1621490114</pub-id>
<pub-id pub-id-type="pmid">28847966</pub-id>
</element-citation>
</ref>
<ref id="CR137">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>ZH</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>XL</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MiR-21 promotes ECM degradation through inhibiting autophagy via the PTEN/akt/mTOR signaling pathway in human degenerated NP cells</article-title>
<source/>Biomed Pharmacother
          <year>2018</year>
<volume>99</volume>
<fpage>725</fpage>
<lpage>734</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopha.2018.01.154</pub-id>
<pub-id pub-id-type="pmid">29710470</pub-id>
</element-citation>
</ref>
<ref id="CR138">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Human aortic smooth muscle cell-derived exosomal miR-221/222 inhibits autophagy via a PTEN/Akt signaling pathway in human umbilical vein endothelial cells</article-title>
<source/>Biochem Biophys Res Commun
          <year>2016</year>
<volume>479</volume>
<issue>2</issue>
<fpage>343</fpage>
<lpage>350</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2016.09.078</pub-id>
<pub-id pub-id-type="pmid">27644883</pub-id>
</element-citation>
</ref>
<ref id="CR139">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MiR-21-5p links epithelial-mesenchymal transition phenotype with stem-like cell signatures via AKT signaling in keloid keratinocytes</article-title>
<source/>Sci Rep
          <year>2016</year>
<volume>6</volume>
<fpage>28281</fpage>
<pub-id pub-id-type="doi">10.1038/srep28281</pub-id>
<pub-id pub-id-type="pmid">27596120</pub-id>
</element-citation>
</ref>
<ref id="CR140">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bahena-Ocampo</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Espinosa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ceballos-Cancino</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lizarraga</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Campos-Arroyo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation</article-title>
<source/>EMBO Rep
          <year>2016</year>
<volume>17</volume>
<issue>5</issue>
<fpage>648</fpage>
<lpage>658</lpage>
<pub-id pub-id-type="doi">10.15252/embr.201540678</pub-id>
<pub-id pub-id-type="pmid">27113763</pub-id>
</element-citation>
</ref>
<ref id="CR141">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis</article-title>
<source/>Nat Cell Biol
          <year>2015</year>
<volume>17</volume>
<issue>9</issue>
<fpage>1169</fpage>
<lpage>1181</lpage>
<pub-id pub-id-type="doi">10.1038/ncb3218</pub-id>
<pub-id pub-id-type="pmid">26280536</pub-id>
</element-citation>
</ref>
<ref id="CR142">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peyrou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bourgoin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Poher</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Altirriba</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Maeder</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Caillon</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice</article-title>
<source/>J Hepatol
          <year>2015</year>
<volume>62</volume>
<issue>2</issue>
<fpage>421</fpage>
<lpage>429</lpage>
<pub-id pub-id-type="doi">10.1016/j.jhep.2014.09.012</pub-id>
<pub-id pub-id-type="pmid">25234947</pub-id>
</element-citation>
</ref>
<ref id="CR143">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ursolic acid improves podocyte injury caused by high glucose</article-title>
<source/>Nephrol Dial Transplant
          <year>2017</year>
<volume>32</volume>
<issue>8</issue>
<fpage>1285</fpage>
<lpage>1293</lpage>
<pub-id pub-id-type="doi">10.1093/ndt/gfv382</pub-id>
<pub-id pub-id-type="pmid">26567247</pub-id>
</element-citation>
</ref>
<ref id="CR144">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis</article-title>
<source/>Sci Rep
          <year>2014</year>
<volume>4</volume>
<fpage>7461</fpage>
<pub-id pub-id-type="doi">10.1038/srep07461</pub-id>
<pub-id pub-id-type="pmid">25514838</pub-id>
</element-citation>
</ref>
<ref id="CR145">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nip</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dar</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Saini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Colden</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Varahram</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chowdhary</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer</article-title>
<source/>Oncotarget
          <year>2016</year>
<volume>7</volume>
<issue>42</issue>
<fpage>68371</fpage>
<lpage>68384</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.12031</pub-id>
<pub-id pub-id-type="pmid">27634912</pub-id>
</element-citation>
</ref>
<ref id="CR146">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wagar</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Shim</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN</article-title>
<source/>Pharm Res
          <year>2011</year>
<volume>28</volume>
<issue>12</issue>
<fpage>3091</fpage>
<lpage>3100</lpage>
<pub-id pub-id-type="doi">10.1007/s11095-011-0570-y</pub-id>
<pub-id pub-id-type="pmid">21853360</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>